US20070031877A1 - Support for analyte determination methods and method for producing the support - Google Patents
Support for analyte determination methods and method for producing the support Download PDFInfo
- Publication number
- US20070031877A1 US20070031877A1 US11/510,565 US51056506A US2007031877A1 US 20070031877 A1 US20070031877 A1 US 20070031877A1 US 51056506 A US51056506 A US 51056506A US 2007031877 A1 US2007031877 A1 US 2007031877A1
- Authority
- US
- United States
- Prior art keywords
- support
- synthesis
- receptors
- support body
- channels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
- G01N21/6454—Individual samples arranged in a regular 2D-array, e.g. multiwell plates using an integrated detector array
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/251—Colorimeters; Construction thereof
- G01N21/253—Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/70—Microphotolithographic exposure; Apparatus therefor
- G03F7/70216—Mask projection systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
- B01J2219/00317—Microwell devices, i.e. having large numbers of wells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00427—Means for dispensing and evacuation of reagents using masks
- B01J2219/00432—Photolithographic masks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00436—Maskless processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00436—Maskless processes
- B01J2219/00439—Maskless processes using micromirror arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00436—Maskless processes
- B01J2219/00441—Maskless processes using lasers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00436—Maskless processes
- B01J2219/00448—Maskless processes using microlens arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00479—Means for mixing reactants or products in the reaction vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00511—Walls of reactor vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00529—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/0059—Sequential processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00646—Making arrays on substantially continuous surfaces the compounds being bound to beads immobilised on the solid supports
- B01J2219/00648—Making arrays on substantially continuous surfaces the compounds being bound to beads immobilised on the solid supports by the use of solid beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00675—In-situ synthesis on the substrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
- B01J2219/00689—Automatic using computers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
- B01J2219/00704—Processes involving means for analysing and characterising the products integrated with the reactor apparatus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00711—Light-directed synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
Definitions
- sequencing provides valuable data for research and applied medicine.
- IVD in vitro diagnosis
- This invention also enables the fast and cost-effective analysis of foodstuffs, for example for the presence of particular genes from pathogenic organisms or from genetically manipulated organisms.
- Biochips are miniaturized hybrid functional elements with biological and technical components, for example biomaterials which are immobilized on the surface of a support and which can act as specific interaction partners (for example DNA oligonucleotides), and a silicon matrix. These functional elements are usually arranged in rows and columns, in which case they are called biochip arrays. Since thousands of biochemical functional elements can be arranged on the biochip, they must be produced by microengineering methods.
- Biochips disclosed to date can be classified by the following criteria:
- Affymetrix uses the principle of photolithography for generation of high density DNA arrays on a planar surface, whereby it has made by far the greatest advances in the parallelization of oligo sequences detection.
- Production takes place by in situ synthesis of DNA oligonucleotides on planar chips in high density (July 1998: up to 64 000 different oligos on 1 cm 2 ).
- the production method is based on photolithography, which is used and has been optimized in the semiconductor industry and which entails use of photoactivatable binding of oligos to the chip surface as well as to oligos already present.
- Production takes several hours due to the large number of process steps.
- Detection takes place by serial optical detection of the planar chip in a fluorescence scanner. Hybridization of the sample on a chip takes about 1.5 hours.
- the invention relates to a method as claimed in claim 1 . for producing a support for determining analytes, comprising the steps of
- the support is a solid phase which can be or is charged with biologically or chemically functional materials or receptors (probes) or building blocks thereof.
- the support has a surface which is provided with depressions, for example at least one channel and particularly preferably with a large number of channels.
- the channels are preferably microchannels with a cross section of, for example, 10 to 1 000 ⁇ m.
- the channels may be—depending on the surface properties—capillary channels, but also channels without capillary action (for example because of Teflon coating).
- the support is preferably optically transparent at least partly in the region of the positions or regions to be charged with receptors.
- the regions of the support which are to be charged with receptors are preferably chemically and physically identical to one another, i.e. they have essentially identical surface characteristics.
- the invention further relates to a method as claimed in claim 14 for integrated synthesis and analyte determination on a support, comprising the steps of
- Claims 15 to 25 relate to preferred refinements of this method. It is also possible to use planar supports in this embodiment.
- Claim 26 relates to a support for determining analytes comprising at least one channel and preferably a large number of channels, in particular capillary channels, whereby a large number of different receptors are immobilized in the channels.
- the support is preferably optically transparent at least in the region of the regions to be charged with receptors.
- the invention further relates to a reagent kit as claimed in claim 28 comprising a support as described above, and building blocks for synthesizing polymeric receptors on the support.
- the reagent kit may additionally comprise reaction liquids for synthesizing the receptors on the support.
- the invention also relates to an apparatus for integrated synthesis and analyte determination on a support as claimed in claim 29 comprising a programmable light source matrix, a detector matrix, a support arranged between light source matrix and detector matrix, and means for supplying fluids into the support and for discharging fluids from the support.
- the programmable light source or illumination matrix may be a reflection matrix, a light valve matrix, for example an LCD matrix or a self-emitting illumination matrix.
- Claims 30 and 31 relate to preferred refinements of these apparatuses.
- the invention also relates to the use of the claimed method, support, reagent kit and the claimed apparatus for determining an analyte in a sample.
- Claims 33 to 38 relate to preferred applications.
- One embodiment of the present invention is represented by a method and system for cyclic integrated synthesis and analysis, which is to be referred to as the ISA system.
- Direct coupling, which is preferred according to the invention, of synthesis end analysis makes high throughput determination of analytes, which is a distinct improvement over the prior art, possible in a cyclic method.
- the substances to be analyzed it is possible in this connection for the substances to be analyzed to be, for example, in the form of segments or fragments of a larger molecule chain.
- a direct logical linkage is provided between the results of the analysis of a first support and the synthesis of the support which is to be subsequently produced, thereby making it possible to transfer the information gained in a preceding cycle to a subsequent cycle. In this way there is stepwise development of learning of the analytical system.
- Said cyclic sequence of synthesis, sequence comparison, analysis of the comparative results and renewed synthesis of receptors on the support can be repeated as often as desired—until a desired termination criterion, which can be chosen as required—is reached.
- the feedback, and the learning process associated therewith, from the preceding cycle takes the method of the invention and the apparatus also suitable for research on very large and complex analyte molecule chains, for example for sequencing in individual genomes, such as the human genome.
- the expenditure of time in this case is improved compared with the prior art by at least one hundred-fold, more probably by one thousand-fold and potentially by 10 000-fold.
- the method can be employed for “new sequencing” of unknown nucleic acid sequences (DNA, cDNA, RNA) including their spatial arrangement, or mapping. It is possible with this procedure to produce an individual gene profile of each individual and each species, whether by sequencing parts of the genome or of the whole genome.
- the method can additionally be employed for “resequencing” of nucleic acid sequences, i.e. for comparing previously known sequences (represented in the form of the receptor probes) with unknown sequences in the sample to be investigated.
- the known sequences are selected appropriately for the problem and specifically for this purpose.
- the described resequencing allows the user to generate individual polymeric receptors on site on the support of the invention starting from a neutral support and subsequently to immediately carry out an analysis of the sample to be investigated. This possibility results in a maximum diversity of variants of the receptors with a minimal space requirement.
- the corresponding receptors or polymer probes for this purpose are usually selected on the basis of known sequences.
- the use of the method for determining gene expression can also take place in the context of high throughput screening.
- the present invention relates to a novel “support” as basis for the use of a preferably light-controlled synthesis of individual bases (G, A, C and T) or oligonucleotides (base sequences) to form a highly parallel, planar and dense arrangement (array) of these oligonucleotides in a solid support matrix (chip).
- the novel biochip comprises a structure of microchannels, preferably capillaries, in an at least partially transparent and preferably flat body.
- the liquid starting materials are passed through the channels in the support and bind, locally activated, to the channel walls.
- the density and parallelity are of the same order of magnitude as for competing techniques, with several hundred thousand defined oligonucleotides on a support.
- the advantage of the novel technique is the more favorable physicochemical properties of the flow and wetting processes in the channels compared with a uniform surface.
- Production of the chips consists of producing a support body, which is preferably provided with microchannels, from a suitable, light-transmitting material, and of the biochemical coating process, preferably on the walls of the individual microchannels, so that subsequent synthesis of the polymeric receptors, for example oligonucleotides, in the channels is possible.
- This entails site-specific attachment of individual receptor building blocks, oligomeric synthons (for example di-, tri-, tetra- or pentanucleotides) or whole base sequences (oligos) in the individual channels in the support by means of photoactivation by a suitable light source.
- each region serves, because of its individual receptor-sequence combination, for the binding and subsequent detection of a specific analyte, for example a DNA fragment.
- the regions are separated from one another in one dimension of the planar support by the walls of the channels, and with photoactivated binding a corresponding free space is left between two adjacent regions along the individual channels. The result is a highly parallel, highly integrated array of specific receptors.
- the investigational material for example DNA, RNA in solution
- the channels For the analysis, the investigational material (for example DNA, RNA in solution) is passed through the channels and has the opportunity to bind to the receptors, for example by hybridization onto complementary strands, if these are present.
- the receptors for example by hybridization onto complementary strands, if these are present.
- the binding of the analyte to the immobilized receptor is [lacuna] by suitable signal-emitting groups known from the prior art, for example light-emitting groups.
- novel detection methods can also be applied. For detection it is possible to do without optically imaging lens systems if the size of the channels is chosen so that each measurement point covers a sufficient number of pixel elements of the detector, for example of a CCD chip.
- the invention thus covers the essential requirements for DNA analysis, namely simultaneous determination of a large number of DNA sequences (achieved by highly integrated, miniaturized supports and high-resolution optical detection), provision of cost-effective tests (multiplexing in production, low-cost disposable supports, for example injection-molded, rapid synthesis during production), rapid procedure for the analysis due to small volumes and favorable wetting processes, reduction in starting materials through the flow geometry of the support etc., rapid evaluation (achieved by parallel optical evaluation in planar arrangements [DNA chip array]), a cost-effective analytical system (achieved by dispensing with costly, microsystem and optical components) and ensuring quality both during production and during analysis (achieved by defined flow processes in the support).
- the mode of achievement in principle in this system is based on stepwise biochemical synthesis of receptors on the surfaces of a large number of channel walls on a support. These channels are arranged on the support, for example a small planar chip.
- the synthesis takes place with the appropriate bases or multi-base oligonucleotides (base sequences) by photoactivated site-specific binding.
- base sequences base sequences
- the support synthesis comprises the provision of the support body, which preferably consists of a suitable, light-transmitting material, and the biochemical generation of receptors on the walls of the individual channels.
- the specific synthesis of the receptors can take place either directly during production of the support body or not until used.
- the support bodies can be used for various materials. It is important that the walls of the channels satisfactorily transmit both the excitation waves for the photoactivated synthesis and the light waves (where appropriate excitation and reaction signal) for the subsequent detection (analysis). Depending on which material is employed, the walls of the channels must be coated with a reactive material so that the receptors or receptor building blocks can bind to the surface.
- the geometry of the supports corresponds, for example, to a “check card”, and the size of the area covered by the channels is determined by the CCD chip used for detection.
- Various methods can be employed to produce the channels in the support. Account must be taken on the influence of the cross-sectional geometry of the channels, which has a great influence on the resulting hydrodynamic forces and the possibility of cleaning the channels. Methods which can be used for production are, for example, laser, milling, etching techniques or injection molding.
- reaction regions intended for coating with receptors in a support body are filled with one or more fluids through channels from containers via feed lines, valves and fittings. It is possible with the aid of a light emission/detection unit which is disclosed in German patent application 198 39 254.0 and which is preferably a programmable light source or illumination matrix, as described in German patent application 199 07 080.6, to illuminate selected positions or regions on the support and, in this way, control the individual synthesis of receptors, the support being in this connection an optofluidic microprocessor. In place of illumination, the selected reaction regions can also undergo individual fluidic activation. After completion of the reaction, the reaction regions are rinsed and refilled, after which another activation cycle follows.
- the progress of receptor synthesis can be followed and controlled by means of suitable detection units.
- the reaction regions are cleaned and are then available for an analyte determination method.
- the sample to be investigated normally contains DNA or RNA. It may be necessary to isolate and replicate these in an amplification step (for example PCR), and moreover acquire a label, for example a dye, fluorescent or luminescent label.
- amplification step for example PCR
- a label for example a dye, fluorescent or luminescent label.
- Sequencing of a DNA molecule is also possible through a sufficiently large number of receptor-charged regions (reaction regions) (Sequencing-by-Hybridization SBH, see BioTec 3/98, pp. 52-58), and other applications show the determination of point mutation polymorphisms (i.e. differences between individuals in single bases in a defined DNA section) and permit, inter alia, identification of such polymorphisms in hundreds of subjects in parallel (Science 280, 5/98, pp. 1077-1082).
- reaction regions receptor-charged regions
- the invention described herein accordingly allows the use of a large number of established methods for investigating nucleic acids and genetic material. This is simultaneously associated with a large increase in such applications and thus an enormous economic advance, because it is expected that the optofluidic microprocessor will provide such technology more flexibly than available methods and at distinctly lower costs.
- receptor building blocks for example single bases (G, A, C, T) or oligonucleotide sequences (preferably about 2 to 4 bases long) in the individual regions by means of photoactivation by a suitable light source.
- the channels are sequentially filled with the synthesis building blocks, for example G, A, C and T, and irradiated site-specifically along the channels with high-resolution light of a particular wavelength and intensity. Between the coating cycles, the channels are appropriately rinsed in order to remove unbound receptor building blocks.
- reaction regions specific binding or hybridization sites
- each reaction region serving, because of its individual receptor sequence, for the binding and subsequent detection of a specific analyte, for example a DNA fragment.
- the reaction regions are separated from one another in one dimension of the planar support by the walls of the channels, and in the second dimension, along the individual channels, a corresponding free space is left between two adjacent reaction regions on photoactivation.
- Photolithography can also be used for the photoactivated binding of the receptor building blocks. However, other methods can also be employed.
- An illumination method using a programmable light source matrix for example a self-luminous light source matrix, a light valve matrix or a reflection matrix, whose matrix points or light source elements can be deliberately controlled, in particular in relation to the intensity and, where appropriate, color of the light, is particularly preferably carried out.
- a programmable light source matrix for example a self-luminous light source matrix, a light valve matrix or a reflection matrix, whose matrix points or light source elements can be deliberately controlled, in particular in relation to the intensity and, where appropriate, color of the light, is particularly preferably carried out.
- a programmable light source matrix for example a self-luminous light source matrix, a light valve matrix or a reflection matrix, whose matrix points or light source elements can be deliberately controlled, in particular in relation to the intensity and, where appropriate, color of the light, is particularly preferably carried out.
- the preferred photoactivation of the oligos for producing the support is effected directly by the illumination matrix.
- the wavelength necessary for this for example 365 nm (upper UV region
- receptors from amino acid or/and peptide building blocks in a corresponding way.
- the binding of a DNA analyte is to lead directly or indirectly to a detectable signal, for example a light signal.
- a detectable signal for example a light signal.
- This can take place, for example, by absorption, an exciting light (fluorescence) or by photon emission (luminescence).
- the signal is detected preferably by use of a CCD chip which is preferably placed directly underneath the support.
- the excitation light source is preferably placed over the support and, correspondingly, the translumination method is used for measurement.
- Each light signal can be detected on the CCD chip, in particular differentially according to intensity and, if required, also according to wavelength (color).
- the recorded spectrum can be evaluated qualitatively or quantitatively.
- differentiation of wavelengths and intensities also allow signal sources to be differentiated.
- excitation light for the detection method must be chosen to be monochromatic (for example laser light for fluorescence excitation) or heterogeneous (for example white light for absorption measurement) depending on requirements.
- novel supports overcome the disadvantages, listed below, of mask-based photolithography methods or in situ spotting.
- the essential advance of the novel supports is the possibility of drastically reducing the production times for the individual synthesis of the receptor-charged supports through appropriate multiplexing between receptor building blocks as starting materials and the channels.
- this principle must in some cases be set aside in the upper planes, i.e. more than one base or oligo must flow through one of the channels for one base, dinucleotide or trinucleotide plane.
- channels very greatly reduces the amount of fluid required and, at the same time, increases the quality both in the synthesis of the support and in the subsequent detection of a sample compared with the use of a single area.
- the uniform wetting of channels is hydrodynamically very simple, consumes little fluid and therefore can be miniaturized and automated very easily. This applies in particular also to the need for adequate quality of the channel washing processes.
- the fluid required is already reduced by 50% by the walls of the channels which, in principle, cover the space between two reaction regions in the support array. This applies both to the coating of the support during production, the synthesis of the receptors and to the “sample loading” for the analysis.
- a further reduction in the amounts of fluid results from the good wetting of the channel walls by a fluid flowing through and, in particular, by the effective washing processes which can, for example, be greatly improved by “cleansing” gas bubbles in the channels.
- good, statistically adequate distribution of the sample on a surface can be achieved only with a very large amount of sample.
- a further advantage of the channels is that the cycle times are shorter, resulting from the smaller volumes of fluid and, associated with this, the faster chemical reactions and operations. This results in both synthesis and hybridization times being shorter.
- a rectangular channel has, provided the height and width are identical, on use of the walls and the top surface four times the reaction surface for an identical-base area, i.e. the same space requirement in the two dimensions of a planar support. Even if hydrodynamic requirements lead to the channels having a round design inside (for example possibilities of better cleaning by gas bubbles in the channel), the reaction surface is still about three times that with a planar surface. The use of this three-dimensional flow geometry makes possible to reduce further the starting material requirement (production and analysis).
- Another effect can likewise be influenced by the cross-sectional geometry of the channels: the reflection of light at the transition from the interior of the channels to the surrounding medium of the supports.
- any curvature has either a focusing or scattering effect on the direction of propagation of the light.
- the light paths can be optimized in the support by appropriate choice of the upper and lower sides of the flow channel geometry.
- Measurement of the light signals of all the reaction regions of the support “all at once” makes use of the continually growing potential of the high-resolution CCD camera chips. These allow detection of all light signals for reaction or hybridization detection in a single measurement procedure.
- current color CCD chips provide about 3 000 ⁇ 3 000 pixels with a pixel size of about 10 ⁇ 10 ⁇ m on an area of 40 ⁇ 40 mm.
- the state of research is already at corresponding CCD chips with about 4 000 ⁇ 6 000 pixels.
- Signal detection takes place synchronously for all pixels in fractions of a second. This means that there is a great growth potential also for the described application of CCD chip technology, and parallel detection of 10 6 individual reaction regions in the support is technically feasible. This avoids the time-consuming scanning procedures of conventional systems, and the pure measurement time is reduced to a minimum and becomes entirely insignificant in relation to other steps in the method.
- Direct detection of the light signals, without an optical system, by a CCD chip has the advantage of a considerably smaller amount of energy required by the light for error-free detection.
- Such an arrangement is said—investigated in a different connection—to consume only 10% of the amount of excitation light of a comparable arrangement with an optical system.
- the optical system consumes 90% of the light energy.
- the lower intensity of light greatly reduces unwanted light-scattering effects in the support surrounding the channels, as well as the possible need to cool the light source used.
- omission of an optical system means a great saving in space and a reduction in the production costs for the detection unit.
- Complicated units for moving the support or the detection unit, as are necessary in scanners, are likewise entirely dispensed with.
- the predetermined dimensions of the CCD chips (several cm 2 ) make it possible to use a very large number of parallel channels (several 100) with a moderate channel size (in the 10-100 ⁇ m range).
- the supports can be designed as simple disposables (disposable chips). Possible in principle are either glass, silicon, metal, ceramic or plastic chips (cost-effective injection molding methods) and other embodiments.
- biochips of other technologies are likewise designed as disposables for a few measurements.
- the very high cost owing to the complicated production of the chips is usually not in favor of disposing of the chip after only one or a few measurements.
- oligonucleotide arrays are specifically synthesized taking account of sequence and gene data-bases on the Internet.
- oligonucleotides as synthetic building blocks makes it possible to achieve a further reduction in the production times. It is possible, especially for simpler arrays, for synthesis units to be used directly by the customer, and thus for the composition of the array to be definitively individualized.
- the great flexibility of the technology is also important in view of the finding that the genes of single individuals vary greatly so that it is not possible to construct a general gene catalog for all species.
- the support makes it possible in this case, for example in a first measurement cycle, to match the basic data which are provided on the Internet—freely accessible or only specifically for the customers of the system—with the individual differences of a patient and, from the results, to form a corresponding second DNA array which carries out the actual tests adapted for the individual.
- the achievement according to the invention can also be used to synthesize peptide sequences in the channels. This would provide highly complex and, at the same time, cost-effective peptide arrays for a large number of applications.
- the advantage of only one channel is that the sample is presented at all measurement points of the array and is therefore particularly suitable for searching for rare constituents.
- a large number of parallel channels has the advantage that the production times for the support synthesis can be minimized through the multiplexing of starting materials and channels and all the flow processes. This channel arrangement is therefore to be preferred for support synthesis and ail analyses with a sufficient number of copies of each analyte in the sample.
- Biacore has designed valves controlled by fluid in a two-part injection molded chip by a membrane which presses from below into the channels on the upper side of the chip and thus closes the channels.
- a possible material for the support is, for example, glass, silicon, ceramic or metal or/and plastic.
- a two-layer structure is possible, and the layers can be joined together for example by gluing or bonding, or not.
- the structure of the channels may in this case be introduced either only into one or else into both sides or halves.
- Fabrication methods which can be used for this purpose are, inter alia, laser or precision milling. Injection molding is particularly cost-effective and allows adequate quality of fabrication. Other methods are the LIGA technique or hot molding.
- the synthesis unit consists of a suitable light source which irradiates site-specifically, With great accuracy and exact resolution, the reaction regions in the support array on synthesis of the receptors, for example bases or base sequences, on the support surface or the channel walls.
- the illumination can take place by means of a programmable light source matrix. It is also possible to use a photolithography unit like those employed in semiconductor chip production for the photoactivated etching of Si wafers.
- the manufacturer carries out the synthesis.
- the latter requires for this purpose an appropriately efficient synthesis unit which uses oligos which are as long as possible (3 or more bases long) as starting materials, which are introduced (injected) in parallel into the channels, and thus minimize the synthesis times for each support (multiplexing). It is possible in this case to provide special accesses in the supports with the aim of obtaining the maximum number of parallel and thus short channels, irrespective of the channel structure provided for the analytical procedure.
- capillary force can in this connection be used in a possible design variant directly for fluid transport in the support. No mechanical system would be used, and the filling of the capillaries with the starting materials and the sample could take place by simply adjusting a valve in the support.
- the “waste chamber” could display a supporting suction effect through embedding a suitable nonwoven material.
- a further variant is vertical alignment of the planar supports, so that gravitational forces can also be utilized for fluid transport in the support. If these forces are insufficient to achieve all the necessary fluid transports into the support, other suitable pumping mechanisms should be provided.
- One possibility for this is electrophoretic movement of the fluids through electrodes integrated into the support, or by reducing the volume in the chambers of the support by appropriate introduction of force from outside into the support (conventional pump).
- the provision of the starting materials for the support synthesis in storage containers offers the advantage of multiplexing of finished base sequences and parallel channels, which is why this design variant is advisable for (ultra)high throughput screening and support manufacturers.
- the multiplexing can take place at the interface to the support in which a specific base sequence wets a different channel for each synthesis cycle.
- a more technically elaborate but, where appropriate, more reliable method is multiplexing in the equipment through an appropriate valve system. Account must be taken here of cross-contamination, which may arise through the use of different base sequences.
- nucleic acid sequences takes place as with other oligonucleotide arrays by hybridization of nucleic acids in the sample material onto complementary strands among the immobilized oligonucleotides.
- peptide sequences in the channels are coupled likewise in accordance with in situ synthesis principles.
- Such peptides are capable of diverse and, in some cases, highly specific binding reactions with peptides, proteins and other substances, so that the range of potential analytes can be considerably extended.
- analytes are nucleic acids (DNA, RNA, in specific cases also PNA). These nucleic acids can be obtained from complete genomes, fragments thereof, chromosomes, plasmids or synthetic sources (for example cDNA). In one embodiment, the sample material may originate from the human genome.
- analytes are proteins, polypeptides and peptides of all types, for example hormones, growth factors, enzymes, tumor antigens, serum factors, antibodies, carbohydrates, for example various sugars in foodstuffs or agricultural crops, functional sugars, polymers and other organic molecules, for example drugs of abuse, pharmaceuticals, metabolites, amino acids, transmitters, pesticides, insecticides, paints, various toxins etc.
- the binding of the analyte to the receptor can in the case of nucleic acids take place by hybridization of complementary nucleic acids, for example longer molecules such as cDNA, synthetic oligonucleotides, PNA, RNA.
- Peptides as receptors for example synthetic peptides or natural peptides, can bind to the analyte via protein-protein or protein-nucleic acid interactions.
- Two principles are preferably employed for signal generation, namely: direct detection of an analyte which was labeled beforehand or during the reaction (preferred method in nucleic acid analysis by means of hybridization) and indirect detection through competition of the analyte or the target sequence with a labeled standard.
- the first variant is well established for some applications, but tends to be rather unsuitable for diagnostics for example of serum components, which is possible with peptide arrays also in the support.
- the second variant is therefore to be preferred for these applications, and it moreover allows in principle, sample preparation by the user to be simpler.
- Direct detection can take place by labeling the analytes with a dye for absorption measurement, a fluorescent dye, labeling the analytes with reporter enzyme, subsequent reaction (for example chemo- or bioluminescence), selective labeling of the bound analyte, for example in the case of nucleic acids by intercalating (fluorescent) dyes, double strand-binding proteins or double strand-binding antibodies or a secondary detection of the bound analyte with a second component, for example in the case of PNA-DNA hybrids by DNA-specific antibodies.
- Labeled standards which can be used are enzyme-coupled standards (for example chemo- and bioluminescence with alkaline phosphatase, peroxidase etc.) or (fluorescence) dye-coupled standards.
- Protein standards can be employed as fusion proteins with a reporter enzyme (see above) or an autofluorescent protein (for example GFP), for example for recombinant antibodies, protein hormones, growth factors etc.
- the sample preparation can take place either manually in the laboratory, in a separate analysis system or in a preparation unit integrated into the same system.
- the sample ready for detection is then introduced into the support by means of manual or automatic pipetting or comparable methods.
- the reading of the light signals for the detection reactions in the support array is to take place in a detection unit where the excitation light source (fluorescence, luminescence or absorption as optical detection) is arranged directly opposite to the CCD chip for light signal measurement.
- the support array is located between light source and detection chip (sandwich architecture).
- An illumination matrix can be used as excitation light source.
- the spatial arrangement of this unit may depend on requirements (for example use of gravitation for flow processes in the chip). This maximally compact architecture minimizes the paths traveled by the light and thus also the intensity of light required. It is intended to dispense with the use of an elaborate, light-consuming and costly optical system which occupies much space, both on the excitation side and on the detection side.
- the temperature control (at present typically 60° C.—most recent developments also now make hybridization possible at 25° C. with low-salt conditions) during the hybridization can take place either by appropriate temperature elements in the detection unit or by the excitation light source or the excitation light per se. Temperature elements in the supports are likewise possible.
- Suitable light sources are, depending on the analyte markers (detection method via absorption or fluorescence etc.), highly parallel light from a lamp (white light), highly parallel light from a flash tube, highly parallel monochromatic light, a monochromatic streak of laser light, extensive illumination through widening of the laser beam, a monochromatic laser beam or a programmable light source matrix.
- An appropriate optical grating or an appropriate optical system can, where appropriate, be provided between excitation light source and support array.
- the detection unit preferably consists of only one CCD chip. These currently have about 2 000 ⁇ 3 000 pixels on an area of, for example, 25 ⁇ 37 mm (Cannon). Arrangement of about 500 parallel channels with a diameter of about 20 ⁇ m (every second double pixel row) on such an area of 25 ⁇ 37 mm results in 750 measurement points (fields) in each channel if only every second double pixel is used under the channel. This would provide 375 000 reaction regions on a single support, each reaction region covering 4 colored and 12 black and white pixels and having an area of 20 ⁇ 20 ⁇ m.
- the light signals must be generated with maximum density on the optical CCD chip so that faulty assignment of light signals and measurement points with their specific base sequence, and overlap of adjacent light signals, can be precluded. Otherwise, serial detection of overlapping regions is possible, or fiber optic elements are employed.
- the detection of the detection reaction can provide both qualitative and quantitative information, in particular which capture molecules (position in the array; have found binding partners evaluation of the, for example, fluorescent label) and how many capture molecules in a class have found a hybridization partner.
- detection in the analytical system is also possible by other, more sensitive sensors.
- This inspection unit comprises an electronically controllable light source matrix and a light sensor matrix which is located opposite to and faces the light source matrix, namely CCD image recorder.
- every second pixel in this arrangement is measured for the photoactivation, it is possible to use the pixels in between, which lie in projection inside a channel, for a permanent process control.
- the pixels in between which lie in projection inside a channel.
- the subsequent detection there could in turn be site-specific and, if necessary, even color-specific light excitation. This results in entirely novel possibilities for detection methods currently not available as yet.
- inspection matrix-CCD unit it is possible to monitor the flow processes in the channels in a support both during the production—i.e. in the oligo synthesis—and during the analysis. For this purpose it is possible to use, for example, cleansing gas bubbles between two fluids in the channels or a coloring of the individual fluids.
- an illumination matrix which generates and transmits the necessary wavelength of, for example, 360-370 nm, for photoinduced elimination of protective groups during the synthesis of DNA oligos on or in the support.
- Detection of the detection reaction in the support can likewise take place in the inspection unit. If the detection is achieved via fluorescent markers, it would be necessary, where appropriate, to change the background illumination (automatically possible). For this purpose it would be possible to use optical filters or/and glass fiber elements (tapers). Where appropriate novel detection methods are also used which is made possible only by the extremely flexible, individual irradiation and detection of the individual reaction region.
- a temperature of about 55-65° C. is required for standard hybridization of DNA, RNA and PNA strands with one another. In the simplest case, this temperature can be generated by the energy emitted by the illumination matrix waste heat and wavelength. This would allow the arrangement to be made more compact.
- the synthesis of DNA molecules in channels can take place with use of standard synthons, for example phosphoramidite building blocks, with suitable protective groups, for example dimethoxytrityl (DMT).
- DMT dimethoxytrityl
- a corresponding fluidic DNA synthesis can take place starting from a linker coupled to the solid phase.
- This format can be combined for the preferred embodiment of the invention with a light-dependent control of the DNA synthesis.
- protective groups which permit light-dependent deprotection are known, so that the protective group, which is usually linked on the 5′ carbon atom of the synthon, is eliminated by light of suitable wavelength.
- the synthesis of nucleic acids with a length of 18 or more nucleotides is possible in capillaries in this way.
- the reaction products can be analyzed, for example by high performance liquid chromatography (HPLC), by detaching the synthesized DNA oligomer, as is possible on use of suitable linkers. In this case it is possible to show the efficiency of the capillary DNA synthesis via the proportion of full-length products.
- HPLC high performance liquid chromatography
- the reaction region on the support is illuminated site- or/and time-specifically with a suitable light source, for example with a mercury vapor lamp, laser light (for example 373 nm nitrogen laser) or with a UV LED.
- a suitable light source for example with a mercury vapor lamp, laser light (for example 373 nm nitrogen laser) or with a UV LED.
- laser light for example 373 nm nitrogen laser
- UV LED for example 373 nm nitrogen laser
- Other light sources which have sufficiently high-energy radiation are likewise suitable too.
- FIG. 1 shows a highly schematic plan view of a support according to the invention.
- FIG. 2 shows examples of channel arrangements in a support according to the invention.
- FIG. 3 shows a diagrammatic depiction of a support in an inspection unit composed of programmable light source matrix and CCD matrix.
- FIG. 4 shows a diagrammatic depiction of an apparatus of the invention for a light-assisted integrated synthesis and analysis method
- FIG. 5 shows the structure from FIG. 4 for a fluidic individualization of reaction regions.
- FIG. 1 shows a transparent support in a plan view in a highly schematic manner.
- the channels 1 which run parallel to one another are evident, for example 500 channels with a length of 37 nm.
- T, G, A, C in FIG. 1 designate reservoirs for the individual starting materials (bases).
- 3 designates the gas inlet.
- 5 identifies a valve.
- 7 identifies the sample input, and 9 designates an entry for further synthetic chemicals and cleaning/washing liquid.
- FIG. 2 is a diagrammatic depiction of other examples of alternative channel arrangements.
- FIG. 3 shows the support of FIG. 1 in an inspection unit composed of programmable light source matrix, for example an LCD matrix, and a CCD detection matrix.
- programmable light source matrix for example an LCD matrix
- CCD detection matrix for example an LCD matrix
- FIG. 4 depicts an apparatus of the invention with an exchangeable support 40 , the structure in principle depending on whether the support is changed in each cycle or only when worn. In the latter case there is cleaning and subsequent reuse of the same channels.
- a programmable light source matrix 30 is depicted. Its programmability can be integrated into the system component 20 , which consists of a calculator or a computer, so that only one freely controllable light source matrix is necessary as component 30 .
- This light source matrix 30 beams light of defined wavelength and intensity onto any addressable sites of an at lens two-dimensional matrix which serves for highly parallel illumination of the reaction regions in the support 40 .
- Said support 40 is irradiated individually by the light source matrix 30 with the computer-controlled light pattern consisting of energy waves in all reaction regions.
- Fluids provided by the fluidics module 60 are transported via the fluidic connection system 64 into the support 40 and conveyed further in its microstructure, which is not depicted in the drawing, in a suitable manner to the reaction regions.
- the support 40 becomes an optofluidic microprocessor in this way. The latter can be either changed after each use or cleaned after each use and changed only for servicing purposes when worn.
- the entering light can be used, for example, for absorption measurements, to activate photoreactions or to excite fluorescence.
- the light emerging from the support 40 or from the optofluidic microprocessor can, for example, be the light from the light source matrix 30 transmitted through the support. It can, however, in this case also comprise light signals which are generated in the individual reaction regions of the support 40 by, for example, fluorescence or luminescence.
- the detector matrix 50 which consists for example of a CCD chip with or without optical system, is arranged in relation to a light source matrix 30 , with a support 40 being located in between, so that the result is a triple matrix arrangement composed of light matrix, support and detector matrix.
- the fluidic module 60 serves to supply the reaction support 40 for example with starting materials, protective gases, chemicals such as solvents etc., and sample material.
- the fluidic module 60 consists of tanks 61 which are emptied in a suitable manner by pumps 62 and valves 63 .
- the tanks can be exchanged or refilled singly or in a cluster.
- Fluids which are required permanently, such as, for example, protective gas, can also be supplied continuously by means of lines (without tanks in the system).
- the fluidic waste from the various methods can be collected either in tanks integrated in the support 40 or in a waste system 65 or, in the case of clusters, outside the individual system.
- the system boundary 10 of the apparatus which can be employed as a single device or else in central or decentral clusters, is likewise depicted. There is always information technology linkage between these clusters.
- the systems located at a site may also be supplied together, by manual operation or automated components, with energy, fluids such as starting materials, reaction chemicals, protective gases and sample material, and with the required supports.
- the system component 20 in the form of a computer or calculator undertakes the control of the system. This includes the control, on the basis of the calculation of the probe or receptor sequences for the individual reaction regions, of the light source matrix 30 and of the fluidic component 60 .
- the data from the detector matrix 50 are moreover collected and evaluated.
- Each apparatus can thus communicate beyond its system boundary 10 with other apparatuses or systems consisting in turn of an apparatus of the invention or other computers or databases. This can take place, for example, via lines, bus systems or via the Internet. It is moreover possible for communication to take place with central coordination by a master computer or as cluster of equal-access systems.
- a data interface 21 to the system environment is likewise provided.
- FIG. 5 shows the structure from FIG. 4 for a fluidic individualization of the reaction regions.
- a support 41 is depicted once again. This is utilized individually under computer control by the fluidic deprotection module 32 .
- the fluids provided by the fluidic module 60 are transported via the fluidic connection system 64 into the support and, in its microstructure which is not depicted in the drawing, conveyed further in a suitable manner to the reaction regions.
- the light emerging from the support or the optofluidic microprocessor can be generated, for example, by luminescence on the reaction regions.
- the fluidic deprotection module 32 is able to bring each reaction region on the support 41 into contact individually with fluids by use of at least one of the wetting components 33 (for example nozzles, capillaries etc.). It is possible in this way to activate, for example, local chemical and biochemical reactions.
- the wetting components 33 for example nozzles, capillaries etc.
- the fluidic module 31 serves to supply the fluidic deprotection module 32 with starting materials or chemicals.
- the fluidic module 31 has a comparable structure to the module 60 and consists, depending on requirements, of tanks, lines, valves etc.
- the detector matrix 50 which consists for example of a CCD chip with or without optical system, is arranged in relation to a fluidic deprotection module 32 , with a support 41 located in between, in such a way that once again a triple matrix arrangement is produced thereby.
- the fluidic module 60 serves to supply the support 41 for example with starting materials, protective gases, chemicals such as solvents etc., and sample material.
- the fluidic module 60 consists of tanks 61 which are emptied in a suitable manner by pumps 62 and valves 63 .
- the tanks can be exchanged or refilled singly or in a cluster.
- Fluids which are required permanently, such as, for example, protective gas, can also be supplied continuously by means of lines (without tanks in the system).
- the fluidic waste from the various methods can be collected either in tanks integrated in the support 41 or in a waste system 65 or, in the case of clusters, outside the individual system.
- the system boundary 10 which has already been explained, of the apparatus and the system component 20 in the form of a computer or calculator, which undertakes the control of the system, is depicted once again. This includes the control of the fluidic modules 31 and 60 , and of the fluidic deprotection module 32 , on the basis of the calculation of the probe sequences for the individual reaction regions. The data from the detector matrix 50 are moreover collected and evaluated.
- Each apparatus can thus communicate beyond its system boundary 10 with other apparatuses or systems consisting in turn of an apparatus of the invention or other computers or databases. This can take place, for example, via lines, bus systems or via the Internet. It is moreover possible for communication to take place with central coordination by a master computer or as cluster of equal-access systems.
- a data interface 21 to the system environment is likewise provided.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Nanotechnology (AREA)
- Clinical Laboratory Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Materials Engineering (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Abstract
A method for producing a support for determining analytes. The method comprises the steps of (a) providing a support comprising at least one channel, comprising a conduit having an intake and an outlet for passing fluid from the intake to the outlet, in the support body, (b) passing liquid with building blocks for synthesizing polymeric receptors through the channel or channels of the support body, (c) site- and/or time-specifically immobilizing the receptor building blocks in each case on predetermined positions in the channel or channels by illumination and (d) repeating steps (b) and (c) until the required receptors have been synthesized in each case on the predetermined positions.
Description
- This application claims priority from U.S. Ser. No. 09/763,914, filed May 11, 2001, which is a 371 filing of PCT/EP99/06317, filed Aug. 27, 1999, both of which are hereby incorporated by reference in their entirety.
- The precise detection of biologically relevant molecules in defined investigation material is of outstanding importance for basic research in the biosciences and for medical diagnostics, and some other disciplines. In this connection, the genetic information is present in the form of an enormous variety of different nucleic acid sequences, the DNA. Realization of this information leads via the production of transcripts of the DNA in RNA usually to the synthesis of proteins, which in turn are frequently involved in biochemical reactions.
- The detection of particular nucleic acids and the determination of the sequence of the four bases in the chain of nucleotides, which is generally referred to as sequencing, provides valuable data for research and applied medicine. In medicine, it has been possible to a greatly increasing extent to develop, through in vitro diagnosis (IVD) instruments for determining important parameters of patients, and to provide the treating physician therewith. Without this instrument, it would be impossible to diagnose many diseases at a sufficiently early time. Genetic analysis has become established here as an important new method, for example for infectious diseases such as HIV and HBV genetic predisposition for certain types of cancer or other diseases, forensic medicine and a large number of other areas of application. It has been possible with close interlinkage of fundamental research and clinical research to trace back and elucidate the molecular causes and (pathological) relationships of some disease states as far as the level of the genetic information. This development is, however, still in its infancy, and much more intensive efforts are needed in particular for conversion into therapeutic strategies. Overall, the genomic sciences and the nucleic acid analytical techniques associated therewith have made enormous contributions both to the understanding of the molecular bases of life and to explaining very complex disease states and pathological processes.
- Further development in medical care will be burdened by the explosion in costs associated with correspondingly elaborate methods. In this connection it is necessary not only to push for implementation of the possibilities for diagnostic and therapeutic benefits, but also to promote integration into a health system which is capable of bearing the load and can be financed.
- Use of corresponding technologies in research can likewise take place on a broad scope and in the academic sector only if the costs associated therewith are reduced.
- The development of the genomic and proteomic sciences and the deciphering of the hereditary material are still at an early stage, as is the realization of the diagnostic potential of a genetic or gene-manipulative analysis. The methods established to date are usually labor-intensive and relatively inefficient, which influences the costs and capacity for example for gaining information. The most important innovation is the development of so-called oligonucleotide arrays in which a very large number of relatively short oligonucleotides of defined sequence are coupled to a solid matrix (usually silicon) and are thus made available for parallel hybridization of complementary sequences in the material to be investigated. The elaborate production and the high cost do not, however, allow marketing as a mass-produced item present.
- 1. Fields of Application
- It is intended to employ distinctly cost-reduced systems to make routine use possible for in vitro diagnostics and clinical diagnostics, for example of infectious diseases (HIV, HBV etc.) and their subtypes, for oncology (early tumor diagnosis, tumor classification, for example type and status), and for determination of a genetic predisposition.
- It is desirable for fundamental biological research, especially genomics, to encompass a very large number of measurement points in the investigated system, for example all expressed genes. This results in an enormous gain in knowledge in fundamental biological research (developmental biology, stem cell culture, tissue engineering, transplantation medicine, regeneration), which will also lead to important break-throughs in biomedicine and corresponding applications.
- As has been shown for the use of DNA chips (Science 280: 1077-1082), it is possible to make a distinction between point mutations in the base sequence through corresponding biochemical conditions of hybridization. The system described therein thus makes extensive screening possible, which can be employed for forensic purposes, for example for convicting those guilty of crimes or for detecting family relationships.
- This invention also enables the fast and cost-effective analysis of foodstuffs, for example for the presence of particular genes from pathogenic organisms or from genetically manipulated organisms.
- The screening of medical products is likewise of great importance. The production of, for example, blood products is still associated with large expenditure ins respect of the safety measures needed for purity. Screening which is efficient in terms of both time and costs for such samples is made possible by this invention in order, for example, to prevent contamination with infectious material (HIV, HBV, HCV etc.).
- 2. Prior Art
- Biochips are miniaturized hybrid functional elements with biological and technical components, for example biomaterials which are immobilized on the surface of a support and which can act as specific interaction partners (for example DNA oligonucleotides), and a silicon matrix. These functional elements are usually arranged in rows and columns, in which case they are called biochip arrays. Since thousands of biochemical functional elements can be arranged on the biochip, they must be produced by microengineering methods.
- Enormous funds are being used, especially in the USA, to promote the development of miniaturized biochips. The most important companies active in this field are listed below:
- Affymetrix, Beckman Instruments, Blue Chip Biosystems, Caliper Technologies, Cura-Gen, Genometrix, Gene Trace Systems, Hyseq, Incyte Pharmaceuticals, Molecular Tool, Nanogen, Pharmacia, Synteni, Third Wave Technologies, Vysis.
- Biochips disclosed to date can be classified by the following criteria:
- Detection principle:
- Chromatographic methods
- Interaction of analytes with solid phase, usually immobilized interaction partners for example hybridization of nucleic acids on DNA oligonucleotides).
- Detection methods (optical, electrical).
- Marker-based detection methods (for example absorption, fluorescence or luminescence) or marker-free detection methods (generation of light to detect the reaction).
- Assignment of the analyte to its support [solid phase] (array, with more than one immobilized interaction partner per support or single, with only one immobilized interaction partner per support).
- Production method (for example photoactivated synthesis of oligonucleotides directly on the biochip, spot completely synthesized oligonucleotides, coat beads or tubes).
- Types of support (glass chips, plastic chips, microtiter plates, tubes or beads).
- Presentation for detection (serially, in parallel).
- Optical detection (serially in a scanner or in parallel with a CCD camera).
- Among the firms listed, only Affymetrix uses the principle of photolithography for generation of high density DNA arrays on a planar surface, whereby it has made by far the greatest advances in the parallelization of oligo sequences detection.
- GeneChip from Affymetrix Inc., Santa Clara, Calif.:
- Production takes place by in situ synthesis of DNA oligonucleotides on planar chips in high density (July 1998: up to 64 000 different oligos on 1 cm2). The production method is based on photolithography, which is used and has been optimized in the semiconductor industry and which entails use of photoactivatable binding of oligos to the chip surface as well as to oligos already present. Production takes several hours due to the large number of process steps. Detection takes place by serial optical detection of the planar chip in a fluorescence scanner. Hybridization of the sample on a chip takes about 1.5 hours. First products (sequencing chip for tumor marker p53 exons 2-11, breast cancer gene BRCA1 exon 11, HIV GeneChip) are already commercially available. The costs at present are in the region of several hundred dollars for one GeneChip, additionally a detection unit is also required.
- Further relevant prior art are WO91/18276, EP-A-0 671 626 and EP-A-0 430 248.
- The invention relates to a method as claimed in
claim 1. for producing a support for determining analytes, comprising the steps of - (a) providing a support body comprising at least one channel,
- (b) passing liquid with building blocks for synthesizing polymeric receptors through the channel or channels of the support body,
- (c) site- or/and time-specifically immobilizing the receptor building blocks in each case on predetermined positions or regions in the channel or channels and
- (d) repeating steps (b) and (c) until the required receptors have been synthesized in each case on the predetermined positions or regions.
- Claims 2 to 13 relate to preferred refinements of this method. The support is a solid phase which can be or is charged with biologically or chemically functional materials or receptors (probes) or building blocks thereof. In this embodiment of the invention, the support has a surface which is provided with depressions, for example at least one channel and particularly preferably with a large number of channels. The channels are preferably microchannels with a cross section of, for example, 10 to 1 000 μm. The channels may be—depending on the surface properties—capillary channels, but also channels without capillary action (for example because of Teflon coating). The support is preferably optically transparent at least partly in the region of the positions or regions to be charged with receptors. The regions of the support which are to be charged with receptors are preferably chemically and physically identical to one another, i.e. they have essentially identical surface characteristics.
- The invention further relates to a method as claimed in claim 14 for integrated synthesis and analyte determination on a support, comprising the steps of
- (a) providing a support body,
- (b) passing a liquid with, present therein, receptors or building blocks for synthesizing polymeric receptors over the support,
- (c) site- or/and time-specifically immobilizing the receptors or receptor building blocks in each case on predetermined positions or regions on the support,
- (d) where appropriate, repeating steps (b) and (c) until the required receptors have been synthesized in each case on the predetermined positions or regions on the support,
- (e) bringing the support into contact with a sample containing analytes to be determined and
- (f) determining the analytes via their binding to the receptors immobilized on the support.
- Claims 15 to 25 relate to preferred refinements of this method. It is also possible to use planar supports in this embodiment.
- Claim 26 relates to a support for determining analytes comprising at least one channel and preferably a large number of channels, in particular capillary channels, whereby a large number of different receptors are immobilized in the channels. The support is preferably optically transparent at least in the region of the regions to be charged with receptors.
- The invention further relates to a reagent kit as claimed in claim 28 comprising a support as described above, and building blocks for synthesizing polymeric receptors on the support. The reagent kit may additionally comprise reaction liquids for synthesizing the receptors on the support.
- The invention also relates to an apparatus for integrated synthesis and analyte determination on a support as claimed in claim 29 comprising a programmable light source matrix, a detector matrix, a support arranged between light source matrix and detector matrix, and means for supplying fluids into the support and for discharging fluids from the support. The programmable light source or illumination matrix may be a reflection matrix, a light valve matrix, for example an LCD matrix or a self-emitting illumination matrix.
Claims - Finally, the invention also relates to the use of the claimed method, support, reagent kit and the claimed apparatus for determining an analyte in a sample. Claims 33 to 38 relate to preferred applications.
- One embodiment of the present invention is represented by a method and system for cyclic integrated synthesis and analysis, which is to be referred to as the ISA system. Direct coupling, which is preferred according to the invention, of synthesis end analysis makes high throughput determination of analytes, which is a distinct improvement over the prior art, possible in a cyclic method. It is possible in this connection for the substances to be analyzed to be, for example, in the form of segments or fragments of a larger molecule chain.
- In a preferred embodiment of the invention, a direct logical linkage is provided between the results of the analysis of a first support and the synthesis of the support which is to be subsequently produced, thereby making it possible to transfer the information gained in a preceding cycle to a subsequent cycle. In this way there is stepwise development of learning of the analytical system.
- Said cyclic sequence of synthesis, sequence comparison, analysis of the comparative results and renewed synthesis of receptors on the support can be repeated as often as desired—until a desired termination criterion, which can be chosen as required—is reached.
- The feedback, and the learning process associated therewith, from the preceding cycle takes the method of the invention and the apparatus also suitable for research on very large and complex analyte molecule chains, for example for sequencing in individual genomes, such as the human genome. The expenditure of time in this case is improved compared with the prior art by at least one hundred-fold, more probably by one thousand-fold and potentially by 10 000-fold.
- The method can be employed for “new sequencing” of unknown nucleic acid sequences (DNA, cDNA, RNA) including their spatial arrangement, or mapping. It is possible with this procedure to produce an individual gene profile of each individual and each species, whether by sequencing parts of the genome or of the whole genome.
- The method can additionally be employed for “resequencing” of nucleic acid sequences, i.e. for comparing previously known sequences (represented in the form of the receptor probes) with unknown sequences in the sample to be investigated. The known sequences are selected appropriately for the problem and specifically for this purpose.
- The described resequencing allows the user to generate individual polymeric receptors on site on the support of the invention starting from a neutral support and subsequently to immediately carry out an analysis of the sample to be investigated. This possibility results in a maximum diversity of variants of the receptors with a minimal space requirement.
- It is possible by combining new sequencing and resequencing to adapt diagnostic tests or medicines to the needs of an individual at short notice.
- It is possible with exceptional flexibility to analyze expression patterns as a further important area of application. The corresponding receptors or polymer probes for this purpose are usually selected on the basis of known sequences. The use of the method for determining gene expression can also take place in the context of high throughput screening.
- In addition, different approaches to screening methods and the setting up and analysis of substance libraries are conceivable with various naturally occurring and artificial receptor probes. This may take place, for example, in connection with the search for and the characterization of pharmacologically active substances.
- The fields of application of the method of the invention and the apparatus of the invention for cyclically integrated synthesis and determination of analytes are wide-ranging and extend in principle to all analytical applications such as gas chromatography, thin-layer chromatography, gel electrophoresis, capillary electrophoresis, mass spectrometry etc. The same applies in principle to all applications of highly parallel solid-phase analysis.
- There is no longer any need at all to store complex polymeric receptors ready for use. In addition, there is no physical restriction on the number and selection of the receptors. The required number of receptors can be distributed over a plurality of reaction supports or a plurality of cycles in a reaction support, because the individual receptors are subject to no site specifications for logical evaluation of the comparative results.
- The present invention relates to a novel “support” as basis for the use of a preferably light-controlled synthesis of individual bases (G, A, C and T) or oligonucleotides (base sequences) to form a highly parallel, planar and dense arrangement (array) of these oligonucleotides in a solid support matrix (chip).
- The novel biochip, the “optofluidic microprocessor”, comprises a structure of microchannels, preferably capillaries, in an at least partially transparent and preferably flat body. On synthesis or immobilization of receptors, the liquid starting materials are passed through the channels in the support and bind, locally activated, to the channel walls. This creates the technical requirements for a rapid, efficient and thus cost-effective production, which will make wide use of these supports possible. The density and parallelity are of the same order of magnitude as for competing techniques, with several hundred thousand defined oligonucleotides on a support. The advantage of the novel technique is the more favorable physicochemical properties of the flow and wetting processes in the channels compared with a uniform surface.
- Production of the chips consists of producing a support body, which is preferably provided with microchannels, from a suitable, light-transmitting material, and of the biochemical coating process, preferably on the walls of the individual microchannels, so that subsequent synthesis of the polymeric receptors, for example oligonucleotides, in the channels is possible. This entails site-specific attachment of individual receptor building blocks, oligomeric synthons (for example di-, tri-, tetra- or pentanucleotides) or whole base sequences (oligos) in the individual channels in the support by means of photoactivation by a suitable light source. This results in a large number of receptor-charged regions (specific binding or hybridization sites) in each channel, and each region serves, because of its individual receptor-sequence combination, for the binding and subsequent detection of a specific analyte, for example a DNA fragment. The regions are separated from one another in one dimension of the planar support by the walls of the channels, and with photoactivated binding a corresponding free space is left between two adjacent regions along the individual channels. The result is a highly parallel, highly integrated array of specific receptors. Because of the possibility of multiplexing oligosequences and parallel channels (for details, see section 5), it is possible to reduce the production times to ¼ on use of single bases, ⅛ with dinuclectides and to 1/16 with trinucleotides by appropriate multiplexing of the oligos (starting materials) and of the channels to be wetted. This also makes flexible adaptation to customers' requirements, the “tailored” biochip, possible. This systematic speeding up is not possible in planar systems (planar chips).
- For the analysis, the investigational material (for example DNA, RNA in solution) is passed through the channels and has the opportunity to bind to the receptors, for example by hybridization onto complementary strands, if these are present. It is preferred to use high-resolution, parallel CCD chips for detection and evaluation of the particular analyte binding, for example a DNA hybridization. The binding of the analyte to the immobilized receptor is [lacuna] by suitable signal-emitting groups known from the prior art, for example light-emitting groups. However, novel detection methods can also be applied. For detection it is possible to do without optically imaging lens systems if the size of the channels is chosen so that each measurement point covers a sufficient number of pixel elements of the detector, for example of a CCD chip. This direct usage (no optical system) of highly parallel CCD matrix chips with a large number (currently 16 million pixels per 1 cm2; research status: 80 million pixels per 1 cm2) of pixels (optical sensors) makes it possible to detect a large number of light signals in parallel (see BioScanner from Genometrix). Therefore it is attempted even for the detection unit to have recourse to a high-tech product fabricated in large numbers and at low cost in place of costly optical arrangements.
- The invention thus covers the essential requirements for DNA analysis, namely simultaneous determination of a large number of DNA sequences (achieved by highly integrated, miniaturized supports and high-resolution optical detection), provision of cost-effective tests (multiplexing in production, low-cost disposable supports, for example injection-molded, rapid synthesis during production), rapid procedure for the analysis due to small volumes and favorable wetting processes, reduction in starting materials through the flow geometry of the support etc., rapid evaluation (achieved by parallel optical evaluation in planar arrangements [DNA chip array]), a cost-effective analytical system (achieved by dispensing with costly, microsystem and optical components) and ensuring quality both during production and during analysis (achieved by defined flow processes in the support).
- The use of photoactivation of chemical reactions in the area of the support synthesis leads, in particular in combination with the technology platform of the optofluidic microprocessor together with a programmable light source matrix, to the breakthrough, because this makes it possible to reduce the production costs for a single support while, at the same time, improving the quality, by a factor of 10-100. In this way, a cost-effective, massively parallel, highly integrated and, at the same time, easily miniaturizable and automatable DNA chip technology is made available for the first time.
- Despite the complex data evaluation, only a minimum of different hardware components is required because the support bodies which need to be changed either for each cycle or only when worn are initially all—before the start of the receptor synthesis—identical. All individuality results only from the specific receptor synthesis and from the information contained stepwise by the analysis which, after the synthesis/analysis cycle, is converted back into information, so that the individuality, i.e. the characterizing features of the biological/chemical material, are once again present only in the form of electronic data.
- The mode of achievement in principle in this system is based on stepwise biochemical synthesis of receptors on the surfaces of a large number of channel walls on a support. These channels are arranged on the support, for example a small planar chip. The synthesis takes place with the appropriate bases or multi-base oligonucleotides (base sequences) by photoactivated site-specific binding. The wetting of these specifically “labeled” channels with the DNA analytes to be investigated and the subsequent detection of the binding reaction via suitable signal-emitting groups concludes a cycle of the method.
- The support synthesis comprises the provision of the support body, which preferably consists of a suitable, light-transmitting material, and the biochemical generation of receptors on the walls of the individual channels. The specific synthesis of the receptors can take place either directly during production of the support body or not until used.
- Various materials (for example glass, silicon, ceramic, metal or plastic) can be used for the support bodies. It is important that the walls of the channels satisfactorily transmit both the excitation waves for the photoactivated synthesis and the light waves (where appropriate excitation and reaction signal) for the subsequent detection (analysis). Depending on which material is employed, the walls of the channels must be coated with a reactive material so that the receptors or receptor building blocks can bind to the surface.
- The geometry of the supports corresponds, for example, to a “check card”, and the size of the area covered by the channels is determined by the CCD chip used for detection. Various methods can be employed to produce the channels in the support. Account must be taken on the influence of the cross-sectional geometry of the channels, which has a great influence on the resulting hydrodynamic forces and the possibility of cleaning the channels. Methods which can be used for production are, for example, laser, milling, etching techniques or injection molding.
- The following aspects must be taken into account in the arrangement of the channels in the plane: if a large number of parallel channels is used, it is possible to minimize the synthesis times, but the wetting or filling of the individual channel is correspondingly complex. If, at the other extreme, there is only a single long channel, the synthesis is correspondingly slow because the multiplexing of channels to bases or whole oligos cannot be used, and all processes can take place only serially one after the other. The advantage of only one channel is for the analysis, where the sample flows past each measurement point in all the channels.
- The positions (reaction regions) intended for coating with receptors in a support body are filled with one or more fluids through channels from containers via feed lines, valves and fittings. It is possible with the aid of a light emission/detection unit which is disclosed in German patent application 198 39 254.0 and which is preferably a programmable light source or illumination matrix, as described in German patent application 199 07 080.6, to illuminate selected positions or regions on the support and, in this way, control the individual synthesis of receptors, the support being in this connection an optofluidic microprocessor. In place of illumination, the selected reaction regions can also undergo individual fluidic activation. After completion of the reaction, the reaction regions are rinsed and refilled, after which another activation cycle follows.
- The progress of receptor synthesis can be followed and controlled by means of suitable detection units.
- As soon as the synthesis of the receptors is completed, the reaction regions are cleaned and are then available for an analyte determination method.
- As already shown for several arrangements (for example Molecular Medicine Today, 9/97, pp. 384-389; Trends in Biotechnology, 11/97, pp. 465-468), it is possible to use the hybridization of nucleic acid strands onto a, usually short, complementary sequence, a so-called oligonucleotide or oligo, for sequence analysis. For this purpose, high-density arrangements of synthetic oligonucleotides are generated onto a solid matrix and permit multiple parallel hybridization experiments. The leading method (August 1998) is a photolithographic and thus local activation of synthesis precursors. Based on the technique which has been learned from the production of microelectronics, the parallel arrangements are referred to as chips.
- An enormous analytical capacity is produced by a massive increase in the number of reaction regions (“measurement points”), i.e. defined oligos at a defined site.
- The sample to be investigated normally contains DNA or RNA. It may be necessary to isolate and replicate these in an amplification step (for example PCR), and moreover acquire a label, for example a dye, fluorescent or luminescent label.
- Sequencing of a DNA molecule is also possible through a sufficiently large number of receptor-charged regions (reaction regions) (Sequencing-by-Hybridization SBH, see
BioTec 3/98, pp. 52-58), and other applications show the determination of point mutation polymorphisms (i.e. differences between individuals in single bases in a defined DNA section) and permit, inter alia, identification of such polymorphisms in hundreds of subjects in parallel (Science 280, 5/98, pp. 1077-1082). - The investigation of whole genomes and of the gene expression status of whole cells also becomes possible for the first time (for example Proc. Nat.
Acad. Sci. USA 95, 3/98, pp. 3752-3757). - The invention described herein accordingly allows the use of a large number of established methods for investigating nucleic acids and genetic material. This is simultaneously associated with a large increase in such applications and thus an enormous economic advance, because it is expected that the optofluidic microprocessor will provide such technology more flexibly than available methods and at distinctly lower costs.
- In the assembly of receptors on the support there is site-specific addition of receptor building blocks, for example single bases (G, A, C, T) or oligonucleotide sequences (preferably about 2 to 4 bases long) in the individual regions by means of photoactivation by a suitable light source. The channels are sequentially filled with the synthesis building blocks, for example G, A, C and T, and irradiated site-specifically along the channels with high-resolution light of a particular wavelength and intensity. Between the coating cycles, the channels are appropriately rinsed in order to remove unbound receptor building blocks.
- This results in a large number of reaction regions (specific binding or hybridization sites) in each channel, each reaction region serving, because of its individual receptor sequence, for the binding and subsequent detection of a specific analyte, for example a DNA fragment. The reaction regions are separated from one another in one dimension of the planar support by the walls of the channels, and in the second dimension, along the individual channels, a corresponding free space is left between two adjacent reaction regions on photoactivation.
- Photolithography can also be used for the photoactivated binding of the receptor building blocks. However, other methods can also be employed.
- An illumination method using a programmable light source matrix, for example a self-luminous light source matrix, a light valve matrix or a reflection matrix, whose matrix points or light source elements can be deliberately controlled, in particular in relation to the intensity and, where appropriate, color of the light, is particularly preferably carried out. Thus, it is possible with such a matrix to generate in each case the required two-dimensional illumination patterns in a simple manner, in particular in a computer-assisted manner. The preferred photoactivation of the oligos for producing the support is effected directly by the illumination matrix. The wavelength necessary for this, for example 365 nm (upper UV region near to visible light), can be controlled with all variants of the programmable light source matrix.
- It is also possible to assemble receptors from amino acid or/and peptide building blocks in a corresponding way.
- As described, the binding of a DNA analyte is to lead directly or indirectly to a detectable signal, for example a light signal. This can take place, for example, by absorption, an exciting light (fluorescence) or by photon emission (luminescence). The signal is detected preferably by use of a CCD chip which is preferably placed directly underneath the support. The excitation light source is preferably placed over the support and, correspondingly, the translumination method is used for measurement. Each light signal can be detected on the CCD chip, in particular differentially according to intensity and, if required, also according to wavelength (color). The recorded spectrum can be evaluated qualitatively or quantitatively. In addition, differentiation of wavelengths and intensities also allow signal sources to be differentiated.
- The types of excitation light for the detection method must be chosen to be monochromatic (for example laser light for fluorescence excitation) or heterogeneous (for example white light for absorption measurement) depending on requirements.
- The novel supports overcome the disadvantages, listed below, of mask-based photolithography methods or in situ spotting.
-
- The principle of extended wetting of the entire chip surface with fluid does not permit any multiplexing in production. Thus, the number of production cycles for 20 base-long oligos increases on use of dinucleotides (42=16 possibilities) from 4×20=80 hybridization steps to 16×10=160, which means a doubling. The same also of course applies to the intermediate washing cycles.
- Synthesis of the photoactivatable bases on the planar chip surface, just like the required washing steps in the production of chips, cannot be achieved except by dipping processes (chip is dipped in the liquid) which involve much space and manipulation, or rinsing processes along the surface, which involves much liquid, (for example centrifugation principle from semiconductor technology), which represents a very great impediment of miniaturization and automation from the viewpoint of equipment development.
- In the subsequent DNA sequence detection, uniform distribution of the sample on the chip surface is complicated (no simple and thus reliable mixing method is possible) and a correspondingly large amount of sample fluid is necessary. The search for a rare event in the sample is impossible because adequate contact of all constituents of sample with all specific measurement points cannot be ensured.
- The essential advance of the novel supports is the possibility of drastically reducing the production times for the individual synthesis of the receptor-charged supports through appropriate multiplexing between receptor building blocks as starting materials and the channels.
- For site-specific generation of a large number of different receptor sequences, for example base sequences of a particular length (for example 20 bases) on a planar surface by means of locally high-resolution photoactivation, 4 (owing to the 4 different bases) synthesis cycles are required in each plane (calculation example: 20 bases in each base sequence of the DNA chip array. There are accordingly 4×20=80 cycles for 20 base planes. On use of dinucleotides (2 bases) on the same surface, 2 planes are produced all at once, but 42=16 synthesis cycles are necessary for these 2 planes. Accordingly, 10×16=160 synthesis cycles are required for 20 planes, instead of 80 cycles, which means a doubling of the production times. On use of trinucleotides (3 bases), this effect is amplified to more than five times the number of cycles. Thus, with a single planar surface, the use of individual bases is the fastest possibility for photoactivated DNA chip production. There is no possibility of reducing the number of synthesis cycles.
- The synthesis of the optofluidic support differs from this in that there is the possibility of distributing the starting materials, i.e. the bases or the different variants of dinucleotides (42=16 combinations) or trinucleotides (43=64 combinations) to various channels. This means that, at least in the lower planes near the support, only one base or one of the possible base sequences is always introduced into each channel. Depending on the specified total number of base sequences to be generated in the channels of the support, it may be that this principle must in some cases be set aside in the upper planes, i.e. more than one base or oligo must flow through one of the channels for one base, dinucleotide or trinucleotide plane. Once again, this increases the number of synthesis cycles somewhat where appropriate. However, overall, there is still a very large reduction in the production times to theoretically ¼ of the cycles with single bases, ⅛ of the cycles with dinucleotides and to 1/16 of the cycles on use of trinucleotides as starting materials for receptor synthesis (and so on for longer oligos). The number of cycles required for a specific support is individual for each support and can be stated only as a statistical average when the number of reaction regions on and in the support, the number of parallel channels and the length of the oligos to be synthesized on the support is predetermined. Optimization of the synthesis times of a support is to take place by means of a software tool to be developed for example CAMS Computer Aided Multiplexing Synthesis) which is integrated in the control of the analytical system to be developed or in the interfaced computer.
- The use of channels very greatly reduces the amount of fluid required and, at the same time, increases the quality both in the synthesis of the support and in the subsequent detection of a sample compared with the use of a single area. Thus, the uniform wetting of channels is hydrodynamically very simple, consumes little fluid and therefore can be miniaturized and automated very easily. This applies in particular also to the need for adequate quality of the channel washing processes.
- The fluid required is already reduced by 50% by the walls of the channels which, in principle, cover the space between two reaction regions in the support array. This applies both to the coating of the support during production, the synthesis of the receptors and to the “sample loading” for the analysis. A further reduction in the amounts of fluid results from the good wetting of the channel walls by a fluid flowing through and, in particular, by the effective washing processes which can, for example, be greatly improved by “cleansing” gas bubbles in the channels. On the other hand, good, statistically adequate distribution of the sample on a surface can be achieved only with a very large amount of sample.
- A further advantage of the channels is that the cycle times are shorter, resulting from the smaller volumes of fluid and, associated with this, the faster chemical reactions and operations. This results in both synthesis and hybridization times being shorter.
- This additionally results in a distinct reduction in errors both in production and in detection, which further increases the number of measurements which can be evaluated per usage of material and time, and forms the basis for quality assurance based on accurately definable and reproducible flow processes.
- The simple miniaturization and automation of the operations in the novel supports form the basis for simple miniaturization and automation of the entire novel analytical system based on the supports.
- It is possible by suitable design of the cross-sectional geometry of the individual channels to increase the useful reaction surface. The size of this area is just as important for the addition of the oligos during production as for the accumulation of the DNA fragments from the sample which are flowing by, and the intensity of the light signals resulting from hybridization.
- Thus, a rectangular channel has, provided the height and width are identical, on use of the walls and the top surface four times the reaction surface for an identical-base area, i.e. the same space requirement in the two dimensions of a planar support. Even if hydrodynamic requirements lead to the channels having a round design inside (for example possibilities of better cleaning by gas bubbles in the channel), the reaction surface is still about three times that with a planar surface. The use of this three-dimensional flow geometry makes possible to reduce further the starting material requirement (production and analysis).
- Another effect can likewise be influenced by the cross-sectional geometry of the channels: the reflection of light at the transition from the interior of the channels to the surrounding medium of the supports. Thus, any curvature has either a focusing or scattering effect on the direction of propagation of the light. Thus, the light paths can be optimized in the support by appropriate choice of the upper and lower sides of the flow channel geometry.
- Measurement of the light signals of all the reaction regions of the support “all at once” makes use of the continually growing potential of the high-resolution CCD camera chips. These allow detection of all light signals for reaction or hybridization detection in a single measurement procedure. For this purpose, current color CCD chips provide about 3 000×3 000 pixels with a pixel size of about 10×10 μm on an area of 40×40 mm. The state of research is already at corresponding CCD chips with about 4 000×6 000 pixels. Signal detection takes place synchronously for all pixels in fractions of a second. This means that there is a great growth potential also for the described application of CCD chip technology, and parallel detection of 106 individual reaction regions in the support is technically feasible. This avoids the time-consuming scanning procedures of conventional systems, and the pure measurement time is reduced to a minimum and becomes entirely insignificant in relation to other steps in the method.
- Processing of the resulting quantities of data is possible without difficulty owing to the development in efficiency with a simultaneous fall in price of modern computer systems.
- Direct detection of the light signals, without an optical system, by a CCD chip has the advantage of a considerably smaller amount of energy required by the light for error-free detection. Such an arrangement is said—investigated in a different connection—to consume only 10% of the amount of excitation light of a comparable arrangement with an optical system. In other words, the optical system consumes 90% of the light energy. The lower intensity of light greatly reduces unwanted light-scattering effects in the support surrounding the channels, as well as the possible need to cool the light source used. In addition, omission of an optical system means a great saving in space and a reduction in the production costs for the detection unit.
- Complicated units for moving the support or the detection unit, as are necessary in scanners, are likewise entirely dispensed with. The predetermined dimensions of the CCD chips (several cm2) make it possible to use a very large number of parallel channels (several 100) with a moderate channel size (in the 10-100 μm range).
- The supports can be designed as simple disposables (disposable chips). Possible in principle are either glass, silicon, metal, ceramic or plastic chips (cost-effective injection molding methods) and other embodiments.
- The biochips of other technologies are likewise designed as disposables for a few measurements. However, in this case, the very high cost owing to the complicated production of the chips is usually not in favor of disposing of the chip after only one or a few measurements.
- The rapid and cost-effective production makes a wide variety of individual applications possible, in which, for example, oligonucleotide arrays are specifically synthesized taking account of sequence and gene data-bases on the Internet.
- It would be possible by use of a single, multiply coiled or spiral channel to establish a hybridization in the (slow) flow-through, which also makes it possible to detect rare events (for example rarely expressed genes). This would introduce a chromatographic principle into DNA array technology.
- The use of di-, tri- or longer oligonucleotides as synthetic building blocks makes it possible to achieve a further reduction in the production times. It is possible, especially for simpler arrays, for synthesis units to be used directly by the customer, and thus for the composition of the array to be definitively individualized.
- The great flexibility of the technology is also important in view of the finding that the genes of single individuals vary greatly so that it is not possible to construct a general gene catalog for all species. The support makes it possible in this case, for example in a first measurement cycle, to match the basic data which are provided on the Internet—freely accessible or only specifically for the customers of the system—with the individual differences of a patient and, from the results, to form a corresponding second DNA array which carries out the actual tests adapted for the individual.
- The achievement according to the invention can also be used to synthesize peptide sequences in the channels. This would provide highly complex and, at the same time, cost-effective peptide arrays for a large number of applications.
- There is a large number of design variants both for the configuration and for the fabrication of the supports. In the arrangement of the channels in the support over the area of the detection unit it is just as conceivable to use only one channel as to arrange a large number of parallel channels. Thus, there are no technical difficulties in fabricating on an area of 25×37 mm an arrangement of 500 channels (state of the art: 500 parallel capillaries with a diameter of 900 nm) with a length of 37 mm and in each case about 750 reaction regions. The same number of reaction regions (500×750=375 000) could also be accommodated in a single serpentine channel with a length of about 20 m.
- The advantage of only one channel is that the sample is presented at all measurement points of the array and is therefore particularly suitable for searching for rare constituents. A large number of parallel channels has the advantage that the production times for the support synthesis can be minimized through the multiplexing of starting materials and channels and all the flow processes. This channel arrangement is therefore to be preferred for support synthesis and ail analyses with a sufficient number of copies of each analyte in the sample.
- In order to benefit from both advantages in one support, it is possible to introduce the starting materials for the support synthesis by means of parallel fittings at the entry to the channels, although the channel consists of only a single long microchannel from the sample input onward. This effect can also take place through the integration of valves in the support or the surrounding equipment components. Thus, Biacore has designed valves controlled by fluid in a two-part injection molded chip by a membrane which presses from below into the channels on the upper side of the chip and thus closes the channels.
- A large number of structures and microchannel courses is possible as arrangement of the channels on the detector area. Parallel or “snake-shaped” structures, for example, are obvious for high parallelity of the fluidic processes. The division of the channels should in this case take place according to the duality principle, where two new channels arise from each channel, and all of them are of equal length. Thus, 10 divisions result in 210=2 048 channels. Spiral arrangements have the advantage that their flow processes are less turbulent and their cleaning is better. Their great disadvantage is the feeding in and out, which must take place in the third dimension upward or downward, which is rather unfavorable in terms of fabrication techniques and optically.
- A possible material for the support is, for example, glass, silicon, ceramic or metal or/and plastic. A two-layer structure is possible, and the layers can be joined together for example by gluing or bonding, or not. The structure of the channels may in this case be introduced either only into one or else into both sides or halves. Fabrication methods which can be used for this purpose are, inter alia, laser or precision milling. Injection molding is particularly cost-effective and allows adequate quality of fabrication. Other methods are the LIGA technique or hot molding.
- There are in principle two possibilities for synthesizing the individual capture receptors, for example oligos, on the reaction regions in the support array. The customer purchases finished supports from the manufacturer with a predetermined selection of immobilized base sequences, or he synthesizes his own chosen sequences on unlabeled supports in a synthesis unit. Information about appropriate sequences can be found, for example, in databases on the Internet, where they are provided freely or else specifically by the support manufacturer.
- The synthesis unit consists of a suitable light source which irradiates site-specifically, With great accuracy and exact resolution, the reaction regions in the support array on synthesis of the receptors, for example bases or base sequences, on the support surface or the channel walls. As already mentioned under 4.4, the illumination can take place by means of a programmable light source matrix. It is also possible to use a photolithography unit like those employed in semiconductor chip production for the photoactivated etching of Si wafers.
- In the case of marketing of finished supports, the manufacturer carries out the synthesis. The latter requires for this purpose an appropriately efficient synthesis unit which uses oligos which are as long as possible (3 or more bases long) as starting materials, which are introduced (injected) in parallel into the channels, and thus minimize the synthesis times for each support (multiplexing). It is possible in this case to provide special accesses in the supports with the aim of obtaining the maximum number of parallel and thus short channels, irrespective of the channel structure provided for the analytical procedure.
- For applications where individual configuration of the arrays, but not rapid synthesis of the supports, is what matters, it is possible to provide the starting materials (G, A, C, T and buffer etc.) directly in the support in corresponding reservoirs. The excess starting materials must be collected in a corresponding chamber in the support. The volume of such a chamber can be designed without difficulty to have a multiple of the total channel volume through an expansion in the third dimension upward or downward. One conceivable application of this support variant is particularly for research laboratories, but also for small medical practices.
- The principle of capillary force can in this connection be used in a possible design variant directly for fluid transport in the support. No mechanical system would be used, and the filling of the capillaries with the starting materials and the sample could take place by simply adjusting a valve in the support. The “waste chamber” could display a supporting suction effect through embedding a suitable nonwoven material. In order to minimize the required amounts of fluid, care should be taken that the capillaries are always of the same length in these one-way flow designs (no circulation and thus no reuse of the starting materials). This is likewise important for the functioning of the capillary force as pump.
- A further variant is vertical alignment of the planar supports, so that gravitational forces can also be utilized for fluid transport in the support. If these forces are insufficient to achieve all the necessary fluid transports into the support, other suitable pumping mechanisms should be provided. One possibility for this is electrophoretic movement of the fluids through electrodes integrated into the support, or by reducing the volume in the chambers of the support by appropriate introduction of force from outside into the support (conventional pump).
- In principle, the provision of the starting materials for the support synthesis in storage containers offers the advantage of multiplexing of finished base sequences and parallel channels, which is why this design variant is advisable for (ultra)high throughput screening and support manufacturers. The multiplexing can take place at the interface to the support in which a specific base sequence wets a different channel for each synthesis cycle. A more technically elaborate but, where appropriate, more reliable method is multiplexing in the equipment through an appropriate valve system. Account must be taken here of cross-contamination, which may arise through the use of different base sequences.
- Another point which must be taken into account is the collection and disposal of excess material at the exit from the individual channels. It is conceivable in this connection both to circulate (reuse the emerging material) and to dispose of the emerging starting materials.
- Analysis of nucleic acid sequences takes place as with other oligonucleotide arrays by hybridization of nucleic acids in the sample material onto complementary strands among the immobilized oligonucleotides.
- As another possible use of the support, is to couple peptide sequences in the channels, likewise in accordance with in situ synthesis principles. Such peptides are capable of diverse and, in some cases, highly specific binding reactions with peptides, proteins and other substances, so that the range of potential analytes can be considerably extended.
- Synthesis in the support would make available for the first time very highly parallel and, at the same time, cost-effective peptide arrays for a large number of applications.
- Examples of analytes are nucleic acids (DNA, RNA, in specific cases also PNA). These nucleic acids can be obtained from complete genomes, fragments thereof, chromosomes, plasmids or synthetic sources (for example cDNA). In one embodiment, the sample material may originate from the human genome.
- Further examples of analytes are proteins, polypeptides and peptides of all types, for example hormones, growth factors, enzymes, tumor antigens, serum factors, antibodies, carbohydrates, for example various sugars in foodstuffs or agricultural crops, functional sugars, polymers and other organic molecules, for example drugs of abuse, pharmaceuticals, metabolites, amino acids, transmitters, pesticides, insecticides, paints, various toxins etc.
- The binding of the analyte to the receptor can in the case of nucleic acids take place by hybridization of complementary nucleic acids, for example longer molecules such as cDNA, synthetic oligonucleotides, PNA, RNA. Peptides as receptors, for example synthetic peptides or natural peptides, can bind to the analyte via protein-protein or protein-nucleic acid interactions.
- Two principles are preferably employed for signal generation, namely: direct detection of an analyte which was labeled beforehand or during the reaction (preferred method in nucleic acid analysis by means of hybridization) and indirect detection through competition of the analyte or the target sequence with a labeled standard. The first variant is well established for some applications, but tends to be rather unsuitable for diagnostics for example of serum components, which is possible with peptide arrays also in the support. The second variant is therefore to be preferred for these applications, and it moreover allows in principle, sample preparation by the user to be simpler.
- Direct detection can take place by labeling the analytes with a dye for absorption measurement, a fluorescent dye, labeling the analytes with reporter enzyme, subsequent reaction (for example chemo- or bioluminescence), selective labeling of the bound analyte, for example in the case of nucleic acids by intercalating (fluorescent) dyes, double strand-binding proteins or double strand-binding antibodies or a secondary detection of the bound analyte with a second component, for example in the case of PNA-DNA hybrids by DNA-specific antibodies. Labeled standards which can be used are enzyme-coupled standards (for example chemo- and bioluminescence with alkaline phosphatase, peroxidase etc.) or (fluorescence) dye-coupled standards. Protein standards can be employed as fusion proteins with a reporter enzyme (see above) or an autofluorescent protein (for example GFP), for example for recombinant antibodies, protein hormones, growth factors etc.
- There are likewise various design variants for the provision of the sample material. The nature of the provision is irrelevant to the actual detection because it is always necessary to provide a sufficient amount of in liquid dissolved DNA fragments at the interface for the desired investigation.
- The sample preparation can take place either manually in the laboratory, in a separate analysis system or in a preparation unit integrated into the same system. The sample ready for detection is then introduced into the support by means of manual or automatic pipetting or comparable methods.
- Precisely when multiplexing is used to reduce the production times in the support synthesis it is possible to achieve identical or even shorter times for the receptor synthesis than would be necessary, for example, for DNA amplification of the sample by PCR. This makes it worthwhile to integrate a PCR into the synthesis system or even into the support for many applications.
- Besides the time-consuming PCR, it is also possible to integrate the preceding cell disruption, for example via readily automatable methods such as ultrasound or high voltage, just like the DNA isolation.
- The reading of the light signals for the detection reactions in the support array is to take place in a detection unit where the excitation light source (fluorescence, luminescence or absorption as optical detection) is arranged directly opposite to the CCD chip for light signal measurement. The support array is located between light source and detection chip (sandwich architecture). An illumination matrix can be used as excitation light source. The spatial arrangement of this unit may depend on requirements (for example use of gravitation for flow processes in the chip). This maximally compact architecture minimizes the paths traveled by the light and thus also the intensity of light required. It is intended to dispense with the use of an elaborate, light-consuming and costly optical system which occupies much space, both on the excitation side and on the detection side.
- The temperature control (at present typically 60° C.—most recent developments also now make hybridization possible at 25° C. with low-salt conditions) during the hybridization can take place either by appropriate temperature elements in the detection unit or by the excitation light source or the excitation light per se. Temperature elements in the supports are likewise possible.
- Suitable light sources are, depending on the analyte markers (detection method via absorption or fluorescence etc.), highly parallel light from a lamp (white light), highly parallel light from a flash tube, highly parallel monochromatic light, a monochromatic streak of laser light, extensive illumination through widening of the laser beam, a monochromatic laser beam or a programmable light source matrix.
- An appropriate optical grating or an appropriate optical system can, where appropriate, be provided between excitation light source and support array.
- The detection unit preferably consists of only one CCD chip. These currently have about 2 000×3 000 pixels on an area of, for example, 25×37 mm (Cannon). Arrangement of about 500 parallel channels with a diameter of about 20 μm (every second double pixel row) on such an area of 25×37 mm results in 750 measurement points (fields) in each channel if only every second double pixel is used under the channel. This would provide 375 000 reaction regions on a single support, each reaction region covering 4 colored and 12 black and white pixels and having an area of 20×20 μm. The light signals must be generated with maximum density on the optical CCD chip so that faulty assignment of light signals and measurement points with their specific base sequence, and overlap of adjacent light signals, can be precluded. Otherwise, serial detection of overlapping regions is possible, or fiber optic elements are employed.
- The resulting large number of measurements (4×500×750=1.5 million colored signals or 4.5 million intensities between 0 and 4 096 digital values) which are available (current CCD chip state of the art) form the basis permitting extensive statistics in the analysis of the detected light signals. The processing of the resulting quantities of data is possible without difficulty through the development in efficiency with, at the same time, fall in price of modern computer systems.
- The detection of the detection reaction can provide both qualitative and quantitative information, in particular which capture molecules (position in the array; have found binding partners evaluation of the, for example, fluorescent label) and how many capture molecules in a class have found a hybridization partner.
- It is possible where appropriate to provide an appropriate optical grating or an appropriate optical system between the support array and the CCD camera.
- If detection with a CCD camera or a CCD chip does not provide adequate signals, detection in the analytical system is also possible by other, more sensitive sensors.
- Of interest in connection with the present invention is the use of an inspection unit as described in the German patent application 198 39254.0. This inspection unit comprises an electronically controllable light source matrix and a light sensor matrix which is located opposite to and faces the light source matrix, namely CCD image recorder.
- It is conceivable in this connection that the user produces his supports himself and uses them directly. He simply downloads the required data (DNA sequences) from a CD-ROM or from the Internet and produces in his illumination matrix-CCD unit his individual DNA chip, then wets it with the sample and reads the signals.
- If, for example, every second pixel in this arrangement is measured for the photoactivation, it is possible to use the pixels in between, which lie in projection inside a channel, for a permanent process control. Thus, for example, it is possible of individual and dynamic following of the flowing in of a gas bubble between two fluids in a channel. It would also be conceivable to color the carrier fluids for G, A, C and T, so that the presence of the correct oligos could be checked and a color change might signal a cross-contamination. In the subsequent detection there could in turn be site-specific and, if necessary, even color-specific light excitation. This results in entirely novel possibilities for detection methods currently not available as yet.
- Using the inspection unit (illumination matrix-CCD unit), it is possible to monitor the flow processes in the channels in a support both during the production—i.e. in the oligo synthesis—and during the analysis. For this purpose it is possible to use, for example, cleansing gas bubbles between two fluids in the channels or a coloring of the individual fluids.
- It is possible to use an illumination matrix which generates and transmits the necessary wavelength of, for example, 360-370 nm, for photoinduced elimination of protective groups during the synthesis of DNA oligos on or in the support.
- Detection of the detection reaction in the support can likewise take place in the inspection unit. If the detection is achieved via fluorescent markers, it would be necessary, where appropriate, to change the background illumination (automatically possible). For this purpose it would be possible to use optical filters or/and glass fiber elements (tapers). Where appropriate novel detection methods are also used which is made possible only by the extremely flexible, individual irradiation and detection of the individual reaction region.
- A temperature of about 55-65° C. is required for standard hybridization of DNA, RNA and PNA strands with one another. In the simplest case, this temperature can be generated by the energy emitted by the illumination matrix waste heat and wavelength. This would allow the arrangement to be made more compact.
- The synthesis of DNA molecules in channels can take place with use of standard synthons, for example phosphoramidite building blocks, with suitable protective groups, for example dimethoxytrityl (DMT). A corresponding fluidic DNA synthesis can take place starting from a linker coupled to the solid phase.
- This format can be combined for the preferred embodiment of the invention with a light-dependent control of the DNA synthesis. For this purpose, protective groups which permit light-dependent deprotection are known, so that the protective group, which is usually linked on the 5′ carbon atom of the synthon, is eliminated by light of suitable wavelength. The synthesis of nucleic acids with a length of 18 or more nucleotides is possible in capillaries in this way.
- The reaction products can be analyzed, for example by high performance liquid chromatography (HPLC), by detaching the synthesized DNA oligomer, as is possible on use of suitable linkers. In this case it is possible to show the efficiency of the capillary DNA synthesis via the proportion of full-length products.
- For light-dependent DNA synthesis, the reaction region on the support is illuminated site- or/and time-specifically with a suitable light source, for example with a mercury vapor lamp, laser light (for example 373 nm nitrogen laser) or with a UV LED. Other light sources which have sufficiently high-energy radiation are likewise suitable too.
-
FIG. 1 shows a highly schematic plan view of a support according to the invention. -
FIG. 2 shows examples of channel arrangements in a support according to the invention. -
FIG. 3 shows a diagrammatic depiction of a support in an inspection unit composed of programmable light source matrix and CCD matrix. -
FIG. 4 shows a diagrammatic depiction of an apparatus of the invention for a light-assisted integrated synthesis and analysis method and -
FIG. 5 shows the structure fromFIG. 4 for a fluidic individualization of reaction regions. -
FIG. 1 shows a transparent support in a plan view in a highly schematic manner. Thechannels 1 which run parallel to one another are evident, for example 500 channels with a length of 37 nm. T, G, A, C inFIG. 1 designate reservoirs for the individual starting materials (bases). 3 designates the gas inlet. 5 identifies a valve. 7 identifies the sample input, and 9 designates an entry for further synthetic chemicals and cleaning/washing liquid. -
FIG. 2 is a diagrammatic depiction of other examples of alternative channel arrangements. -
FIG. 3 shows the support ofFIG. 1 in an inspection unit composed of programmable light source matrix, for example an LCD matrix, and a CCD detection matrix. -
FIG. 4 depicts an apparatus of the invention with anexchangeable support 40, the structure in principle depending on whether the support is changed in each cycle or only when worn. In the latter case there is cleaning and subsequent reuse of the same channels. A programmablelight source matrix 30 is depicted. Its programmability can be integrated into thesystem component 20, which consists of a calculator or a computer, so that only one freely controllable light source matrix is necessary ascomponent 30. Thislight source matrix 30 beams light of defined wavelength and intensity onto any addressable sites of an at lens two-dimensional matrix which serves for highly parallel illumination of the reaction regions in thesupport 40. Saidsupport 40 is irradiated individually by thelight source matrix 30 with the computer-controlled light pattern consisting of energy waves in all reaction regions. Fluids provided by thefluidics module 60 are transported via thefluidic connection system 64 into thesupport 40 and conveyed further in its microstructure, which is not depicted in the drawing, in a suitable manner to the reaction regions. Thesupport 40 becomes an optofluidic microprocessor in this way. The latter can be either changed after each use or cleaned after each use and changed only for servicing purposes when worn. - The entering light can be used, for example, for absorption measurements, to activate photoreactions or to excite fluorescence.
- The light emerging from the
support 40 or from the optofluidic microprocessor can, for example, be the light from thelight source matrix 30 transmitted through the support. It can, however, in this case also comprise light signals which are generated in the individual reaction regions of thesupport 40 by, for example, fluorescence or luminescence. - The
detector matrix 50, which consists for example of a CCD chip with or without optical system, is arranged in relation to alight source matrix 30, with asupport 40 being located in between, so that the result is a triple matrix arrangement composed of light matrix, support and detector matrix. - The
fluidic module 60 serves to supply thereaction support 40 for example with starting materials, protective gases, chemicals such as solvents etc., and sample material. Thefluidic module 60 consists oftanks 61 which are emptied in a suitable manner bypumps 62 andvalves 63. The tanks can be exchanged or refilled singly or in a cluster. Fluids which are required permanently, such as, for example, protective gas, can also be supplied continuously by means of lines (without tanks in the system). The fluidic waste from the various methods can be collected either in tanks integrated in thesupport 40 or in awaste system 65 or, in the case of clusters, outside the individual system. - The
system boundary 10 of the apparatus, which can be employed as a single device or else in central or decentral clusters, is likewise depicted. There is always information technology linkage between these clusters. The systems located at a site may also be supplied together, by manual operation or automated components, with energy, fluids such as starting materials, reaction chemicals, protective gases and sample material, and with the required supports. - The
system component 20 in the form of a computer or calculator undertakes the control of the system. This includes the control, on the basis of the calculation of the probe or receptor sequences for the individual reaction regions, of thelight source matrix 30 and of thefluidic component 60. The data from thedetector matrix 50 are moreover collected and evaluated. - Each apparatus can thus communicate beyond its
system boundary 10 with other apparatuses or systems consisting in turn of an apparatus of the invention or other computers or databases. This can take place, for example, via lines, bus systems or via the Internet. It is moreover possible for communication to take place with central coordination by a master computer or as cluster of equal-access systems. Adata interface 21 to the system environment is likewise provided. -
FIG. 5 shows the structure fromFIG. 4 for a fluidic individualization of the reaction regions. A support 41 is depicted once again. This is utilized individually under computer control by the fluidic deprotection module 32. The fluids provided by thefluidic module 60 are transported via thefluidic connection system 64 into the support and, in its microstructure which is not depicted in the drawing, conveyed further in a suitable manner to the reaction regions. This makes the support 41 into an optofluidic microprocessor. The latter can be either changed after each use or cleaned after each use and changed only for servicing purposes when worn. - It is possible to feed light into this support for example from above or/and from the side to excite fluorescence reactions etc.
- The light emerging from the support or the optofluidic microprocessor can be generated, for example, by luminescence on the reaction regions.
- The fluidic deprotection module 32 is able to bring each reaction region on the support 41 into contact individually with fluids by use of at least one of the wetting components 33 (for example nozzles, capillaries etc.). It is possible in this way to activate, for example, local chemical and biochemical reactions.
- The
fluidic module 31 serves to supply the fluidic deprotection module 32 with starting materials or chemicals. Thefluidic module 31 has a comparable structure to themodule 60 and consists, depending on requirements, of tanks, lines, valves etc. - The
detector matrix 50, which consists for example of a CCD chip with or without optical system, is arranged in relation to a fluidic deprotection module 32, with a support 41 located in between, in such a way that once again a triple matrix arrangement is produced thereby. - The
fluidic module 60 serves to supply the support 41 for example with starting materials, protective gases, chemicals such as solvents etc., and sample material. Thefluidic module 60 consists oftanks 61 which are emptied in a suitable manner bypumps 62 andvalves 63. The tanks can be exchanged or refilled singly or in a cluster. Fluids which are required permanently, such as, for example, protective gas, can also be supplied continuously by means of lines (without tanks in the system). The fluidic waste from the various methods can be collected either in tanks integrated in the support 41 or in awaste system 65 or, in the case of clusters, outside the individual system. - The
system boundary 10, which has already been explained, of the apparatus and thesystem component 20 in the form of a computer or calculator, which undertakes the control of the system, is depicted once again. This includes the control of thefluidic modules detector matrix 50 are moreover collected and evaluated. - Each apparatus can thus communicate beyond its
system boundary 10 with other apparatuses or systems consisting in turn of an apparatus of the invention or other computers or databases. This can take place, for example, via lines, bus systems or via the Internet. It is moreover possible for communication to take place with central coordination by a master computer or as cluster of equal-access systems. Adata interface 21 to the system environment is likewise provided.
Claims (33)
1. A method for producing a support for determining an analyte, comprising:
(a) providing an unlabelled support body
(b) inserting the support body into a synthesis unit,
(c) obtaining information from a database about sequences of receptors to be synthesized on the support,
(d) passing liquid containing receptor building blocks over the support body,
(e) site- or/and time-specific immobilising of the receptor building blocks at respective predetermined positions on the support body and
(f) repeating steps (d) to (e), until the desired receptors have been synthesized at the respective predetermined positions.
2. The method of claim 1 wherein the unlabelled support body of step (a) is provided by a manufacturer and is delivered to the owner of the synthesis unit of (b).
3. The method of claim 1 wherein in step (c) the sequences are taken from a freely accessible database.
4. The method of claim 1 , wherein in step (c) the sequences are taken from a database provided by the manufacturer of the unlabelled support body of (a).
5. The method of claim 1 , further comprising using the support for determining analytes in a sample.
6. The method as claimed in claim 5 , further comprising carrying out a plurality of synthesis/analyte determination cycles wherein the receptors for a subsequent cycle are synthesized on the basis of the information from a preceding cycle.
7. The method of claim 5 , wherein the sample is derived from a patient.
8. The method of claim 7 , further comprising adjusting the results of the determination to the individual differences of the patient and from the results, forming a second support on which a determination adapted to the individual patient is carried out.
9. The method of claim 5 , further comprising inserting the support body into an integrated synthesis and analysis unit, contacting the carrier, after the synthesis of the receptors, with a sample containing analytes and determining the analytes by their binding to the receptors immobilized on the support.
10. The method of claim 1 , wherein the support body comprises at least one channel.
11. The method of claim 1 , wherein the support body comprises a plurality of channels.
12. The method of claim 11 , wherein the channels are assembled parallel to one another.
13. The method of claim 1 , wherein the receptors are selected from nucleic acids and nucleic acid analogues.
14. The method of claim 13 , wherein the receptor building blocks are selected from nucleosides, oligonucleotides, nucleotide analogues and oligonucleotide analogues.
15. The method of claim 1 , wherein the receptors are selected from polypeptides.
16. The method of claim 15 , wherein the receptor building blocks are selected from amino acids and peptides.
17. The method of claim 1 , further comprising providing a reagent comprising a support and building blocks for the synthesis of polymeric receptors on the support.
18. The method of claim 1 , further comprising inserting the support body into a synthesis unit comprising a programmable light source matrix, a detector matrix, a means for supplying fluids to the support, and for discharging fluids from the support, and an electronic control and regulation means, wherein the support body is accommodated between the programmable light source matrix and the detector matrix.
19. The method of claim 1 , wherein the synthesis unit further comprises a means for deprotecting reaction components on the support.
20. The method of claim 1 further comprising sequencing nucleic acids.
21. The method of claim 20 wherein said sequencing is new sequencing.
22. The method of claim 21 , wherein the genetic material is selected from the group consisting of individual genomes and synthetic nucleic acids.
23. The method of claim 1 further comprising obtaining diagnostic information.
24. The method of claim 24 , wherein the diagnostic information is the individual effect of pharmaceuticals.
25. The method of claim 24 further comprising managing individual patients.
26. The method of claim 1 further comprising analyzing the effect of pharmacological substances.
27. The method of claim 1 further comprising manufacturing and analyzing substance libraries.
28. The method of claim 1 further comprising comparing individuals in a population.
29. A system for integrated synthesis of receptors on a support, comprising:
(a) a support body,
(b) a synthesis unit,
(c) a means for the synthesis of receptors by step-by-step assembly of receptor building blocks at respective predetermined positions on the support and
(d) a database for obtaining information about sequences of receptors to be synthesized on the support.
30. The system of claim 30 , wherein the support body comprises at least one channel.
31. The system of claim 30 , wherein the synthesis unit comprises a programmable light source matrix, a detector matrix, a means for supplying fluids to the support, and for discharging fluids from the support, and an electronic control and regulation means.
32. The system according to claim 31 , wherein the support body is arranged between the programmable light source matrix and the detector matrix.
33. The method of claim 20 wherein said sequencing is resequencing complex genetic material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/510,565 US20070031877A1 (en) | 1998-08-28 | 2006-08-28 | Support for analyte determination methods and method for producing the support |
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19839256 | 1998-08-28 | ||
DE19839254 | 1998-08-28 | ||
DE19839255 | 1998-08-28 | ||
DE19907080.6 | 1999-02-19 | ||
DE19907080 | 1999-02-19 | ||
DE19924327 | 1999-05-27 | ||
DE19924327.1 | 1999-05-27 | ||
DE19839255.9 | 1999-05-27 | ||
DE19839256.7 | 1999-05-27 | ||
DE19839254.0 | 1999-05-27 | ||
US09/763,914 US7097974B1 (en) | 1998-08-28 | 1999-08-27 | Support for a method for determining an analyte and a method for producing the support |
PCT/EP1999/006317 WO2000013018A2 (en) | 1998-08-28 | 1999-08-27 | Support for a method for determining analytes and a method for producing the support |
US11/510,565 US20070031877A1 (en) | 1998-08-28 | 2006-08-28 | Support for analyte determination methods and method for producing the support |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/763,914 Continuation US7097974B1 (en) | 1998-08-28 | 1999-08-27 | Support for a method for determining an analyte and a method for producing the support |
PCT/EP1999/006317 Continuation WO2000013018A2 (en) | 1998-08-28 | 1999-08-27 | Support for a method for determining analytes and a method for producing the support |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070031877A1 true US20070031877A1 (en) | 2007-02-08 |
Family
ID=27512654
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/763,607 Expired - Fee Related US7737088B1 (en) | 1998-08-28 | 1999-08-27 | Method and device for producing biochemical reaction supporting materials |
US09/763,914 Expired - Fee Related US7097974B1 (en) | 1998-08-28 | 1999-08-27 | Support for a method for determining an analyte and a method for producing the support |
US10/727,566 Abandoned US20040175734A1 (en) | 1998-08-28 | 2003-12-05 | Support for analyte determination methods and method for producing the support |
US11/510,565 Abandoned US20070031877A1 (en) | 1998-08-28 | 2006-08-28 | Support for analyte determination methods and method for producing the support |
US11/971,805 Abandoned US20080214412A1 (en) | 1998-08-28 | 2008-01-09 | Method and device for preparing and/or analyzing biochemical reaction carriers |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/763,607 Expired - Fee Related US7737088B1 (en) | 1998-08-28 | 1999-08-27 | Method and device for producing biochemical reaction supporting materials |
US09/763,914 Expired - Fee Related US7097974B1 (en) | 1998-08-28 | 1999-08-27 | Support for a method for determining an analyte and a method for producing the support |
US10/727,566 Abandoned US20040175734A1 (en) | 1998-08-28 | 2003-12-05 | Support for analyte determination methods and method for producing the support |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/971,805 Abandoned US20080214412A1 (en) | 1998-08-28 | 2008-01-09 | Method and device for preparing and/or analyzing biochemical reaction carriers |
Country Status (8)
Country | Link |
---|---|
US (5) | US7737088B1 (en) |
EP (6) | EP2273270A1 (en) |
JP (3) | JP2002525590A (en) |
AT (4) | ATE481637T1 (en) |
AU (3) | AU749884B2 (en) |
CA (2) | CA2341894A1 (en) |
DE (8) | DE19940751A1 (en) |
WO (3) | WO2000013018A2 (en) |
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089916A1 (en) * | 2003-10-28 | 2005-04-28 | Xiongwu Xia | Allele assignment and probe selection in multiplexed assays of polymorphic targets |
US20050272049A1 (en) * | 2000-06-21 | 2005-12-08 | Sukanta Banerjee | Arrays of magnetic particles |
US20060228740A1 (en) * | 1996-04-25 | 2006-10-12 | Michael Seul | Light-controlled electrokinetic assembly of particles near surfaces |
US20060228741A1 (en) * | 1996-04-25 | 2006-10-12 | Seul Michael | Light-controlled electrokinetic assembly of particles near surfaces |
US20080140452A1 (en) * | 2004-07-09 | 2008-06-12 | Michael Seul | Transfusion registry network for genetically characterized blood products |
US20080160548A1 (en) * | 2005-04-20 | 2008-07-03 | Micronas Gmbh | Microoptical Detection System and Method for Determination of Temperature-Dependent Parameters of Analytes |
US20100331213A1 (en) * | 2003-09-22 | 2010-12-30 | Bioarray Solutions, Ltd. | Microparticles with enhanced covalent binding capacity and their uses |
US20110184655A1 (en) * | 2003-09-18 | 2011-07-28 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
US8563247B2 (en) | 2003-10-29 | 2013-10-22 | Bioarray Solutions, Ltd. | Kits for multiplexed nucleic acid analysis by capture of single-stranded DNA produced from double-stranded target fragments |
US8712123B2 (en) | 2002-11-15 | 2014-04-29 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
US8795960B2 (en) | 2003-10-28 | 2014-08-05 | Bioarray Solutions, Ltd. | Optimization of gene expression analysis using immobilized capture probes |
US9147037B2 (en) | 2004-08-02 | 2015-09-29 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
US9403141B2 (en) | 2013-08-05 | 2016-08-02 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US9436088B2 (en) | 2001-06-21 | 2016-09-06 | Bioarray Solutions, Ltd. | Un-supported polymeric film with embedded microbeads |
US9677067B2 (en) | 2015-02-04 | 2017-06-13 | Twist Bioscience Corporation | Compositions and methods for synthetic gene assembly |
US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
US9895673B2 (en) | 2015-12-01 | 2018-02-20 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
US10053688B2 (en) | 2016-08-22 | 2018-08-21 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
US10415081B2 (en) | 2001-10-15 | 2019-09-17 | Bioarray Solutions Ltd. | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
US10696965B2 (en) | 2017-06-12 | 2020-06-30 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
US10844373B2 (en) | 2015-09-18 | 2020-11-24 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
US10894242B2 (en) | 2017-10-20 | 2021-01-19 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
US10894959B2 (en) | 2017-03-15 | 2021-01-19 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
US10907274B2 (en) | 2016-12-16 | 2021-02-02 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
US10936953B2 (en) | 2018-01-04 | 2021-03-02 | Twist Bioscience Corporation | DNA-based digital information storage with sidewall electrodes |
US11332738B2 (en) | 2019-06-21 | 2022-05-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
US11377676B2 (en) | 2017-06-12 | 2022-07-05 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
US11492727B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for GLP1 receptor |
US11492728B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
US11492665B2 (en) | 2018-05-18 | 2022-11-08 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
US11512347B2 (en) | 2015-09-22 | 2022-11-29 | Twist Bioscience Corporation | Flexible substrates for nucleic acid synthesis |
US11550939B2 (en) | 2017-02-22 | 2023-01-10 | Twist Bioscience Corporation | Nucleic acid based data storage using enzymatic bioencryption |
US11684903B2 (en) | 2018-10-24 | 2023-06-27 | Daniel Shafer | Microscale chemical reactors |
US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
US12173282B2 (en) | 2019-09-23 | 2024-12-24 | Twist Bioscience, Inc. | Antibodies that bind CD3 epsilon |
Families Citing this family (215)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2332645A1 (en) | 1998-02-11 | 2011-06-15 | The University Of Houston | Apparatus for chemical and biochemical reactions using photo-generated reagents |
US7101914B2 (en) | 1998-05-04 | 2006-09-05 | Natural Asa | Isomer enriched conjugated linoleic acid compositions |
US6271957B1 (en) | 1998-05-29 | 2001-08-07 | Affymetrix, Inc. | Methods involving direct write optical lithography |
DE19940751A1 (en) | 1998-08-28 | 2000-03-02 | Febit Ferrarius Biotech Gmbh | Apparatus for detecting light emissions comprises light-emitting matrix facing light-detection matrix, which together sandwich test substance |
NZ511560A (en) * | 1998-11-05 | 2002-11-26 | Chemometec As | A method for the assessment of particles and a system and a device for use in the method |
WO2000049142A1 (en) | 1999-02-19 | 2000-08-24 | Febit Ferrarius Biotechnology Gmbh | Method for producing polymers |
AU4698600A (en) * | 1999-05-05 | 2000-11-17 | Ut-Battelle, Llc | Method and apparatus for combinatorial chemistry |
US20050279949A1 (en) | 1999-05-17 | 2005-12-22 | Applera Corporation | Temperature control for light-emitting diode stabilization |
US7410793B2 (en) | 1999-05-17 | 2008-08-12 | Applera Corporation | Optical instrument including excitation source |
US7387891B2 (en) | 1999-05-17 | 2008-06-17 | Applera Corporation | Optical instrument including excitation source |
IL147227A0 (en) * | 1999-07-02 | 2002-08-14 | Clondiag Chip Tech Gmbh | Microchip matrix device for duplicating and characterizing nucleic acids |
JP2001078175A (en) * | 1999-07-07 | 2001-03-23 | Fuji Photo Film Co Ltd | Fluorescent observation device |
JP2001070227A (en) | 1999-07-07 | 2001-03-21 | Fuji Photo Film Co Ltd | Fluorescent observing device |
US6867851B2 (en) | 1999-11-04 | 2005-03-15 | Regents Of The University Of Minnesota | Scanning of biological samples |
US6784982B1 (en) | 1999-11-04 | 2004-08-31 | Regents Of The University Of Minnesota | Direct mapping of DNA chips to detector arrays |
US20050164293A1 (en) * | 1999-11-29 | 2005-07-28 | Peer Stahler | Dynamic determination of analytes |
DE19962803A1 (en) * | 1999-12-23 | 2001-07-05 | Basf Ag | Process and device for mask-free production of biopolymers |
DE10024132B4 (en) * | 2000-01-28 | 2007-03-22 | Leica Microsystems Cms Gmbh | Arrangement for detecting fluorescent light of several sample points |
DE10013254A1 (en) | 2000-03-17 | 2001-10-04 | Friz Biochem Gmbh | New apparatus, useful for detecting biomolecules and polymers, comprises array of samples containing specific molecules with separate light sources and system for detecting which samples interact with molecule to be detected |
WO2001077271A2 (en) | 2000-04-06 | 2001-10-18 | Conlinco, Inc. | Conjugated linoleic acid compositions |
WO2001078531A2 (en) | 2000-04-18 | 2001-10-25 | Natural As | Conjugated linoleic acid powder |
DE10023423B4 (en) * | 2000-05-12 | 2009-03-05 | Gnothis Holding Sa | Direct detection of single molecules |
AU2001271893A1 (en) * | 2000-07-07 | 2002-01-21 | Nimblegen Systems, Inc. | Method and apparatus for synthesis of arrays of dna probes |
US6576472B1 (en) * | 2000-07-26 | 2003-06-10 | Smithkline Beecham Corporation | Chemical constructs for solution phase chemistry |
DE10036457A1 (en) * | 2000-07-26 | 2002-02-14 | Giesing Michael | Use of an imaging photoelectric area sensor for evaluating biochips and imaging processes therefor |
US6545758B1 (en) | 2000-08-17 | 2003-04-08 | Perry Sandstrom | Microarray detector and synthesizer |
US6567163B1 (en) | 2000-08-17 | 2003-05-20 | Able Signal Company Llc | Microarray detector and synthesizer |
FR2813121A1 (en) | 2000-08-21 | 2002-02-22 | Claude Weisbuch | PERFECTED DEVICE FOR SUPPORTING CHROMOPHORIC ELEMENTS |
DE10051396A1 (en) | 2000-10-17 | 2002-04-18 | Febit Ferrarius Biotech Gmbh | An integrated synthesis and identification of an analyte, comprises particles immobilized at a carrier to be coupled to receptors in a structured pattern to give receptor arrays for biochemical reactions |
AU2002210552A1 (en) * | 2000-10-17 | 2002-04-29 | Febit Ag | Method and device for the integrated synthesis and analysis of analytes on a support |
DE10058095C2 (en) * | 2000-11-03 | 2003-12-18 | Fraunhofer Ges Forschung | Device for the determination of analytes by chemiluminescence |
GB2368903A (en) * | 2000-11-08 | 2002-05-15 | Proimmune Ltd | Analysis of biological and biochemical assays |
DE10060433B4 (en) * | 2000-12-05 | 2006-05-11 | Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. | Method for producing a fluid component, fluid component and analysis device |
DE10062244A1 (en) * | 2000-12-14 | 2002-07-04 | Infineon Technologies Ag | Sensor for the detection of macromolecular biopolymers, sensor arrangement, method for the detection of macromolecular biopolymers and method for producing a sensor for the detection of macromolecular biopolymers |
DE10103954B4 (en) * | 2001-01-30 | 2005-10-06 | Advalytix Ag | Method for analyzing macromolecules |
DE10113711A1 (en) * | 2001-03-16 | 2002-09-26 | Lifebits Ag | Identifying bio-chemical reactions e.g., DNA hybridization, comprises digitally scanning specific detector molecules in an array of accurately-defined and discrete points with a sample, for statistical evaluation |
WO2002078906A2 (en) * | 2001-03-29 | 2002-10-10 | Cellect Technologies Corp. | Methods devices and systems for sorting and separating particles |
DE10115474A1 (en) * | 2001-03-29 | 2002-10-10 | Infineon Technologies Ag | Microfluid channel structure used for carrying out chemical, biological and/or physical processes comprises channel sections arranged in series with a microchannel between connections in the flow direction of the medium |
US20020160427A1 (en) * | 2001-04-27 | 2002-10-31 | Febit Ag | Methods and apparatuses for electronic determination of analytes |
DE10122357A1 (en) * | 2001-05-09 | 2002-11-14 | Febit Ferrarius Biotech Gmbh | Hybrid process for the production of supports for analyte determination |
EP1397668A2 (en) * | 2001-06-06 | 2004-03-17 | Digital Optical Imaging Corporation | Light modulated microarray reader and methods relating thereto |
DE10156329A1 (en) * | 2001-07-17 | 2003-02-06 | Frieder Breitling | Method and arrangement for attaching substances immobilized in transport means as well as monomer particles |
DE10133844B4 (en) * | 2001-07-18 | 2006-08-17 | Micronas Gmbh | Method and device for detecting analytes |
DE10136008B4 (en) * | 2001-07-24 | 2005-03-31 | Advalytix Ag | Method for analyzing macromolecules and method for producing an analysis device |
DE10142691B4 (en) * | 2001-08-31 | 2006-04-20 | Infineon Technologies Ag | Method for detecting biochemical reactions and a device therefor |
JP2005518553A (en) | 2001-09-06 | 2005-06-23 | ジェノミック プロファイリング システムズ インコーポレイティッド | Rapid and sensitive detection method for cells and viruses |
DE10145701A1 (en) * | 2001-09-17 | 2003-04-10 | Infineon Technologies Ag | Fluorescence biosensor chip and fluorescence biosensor chip arrangement |
DE10145700A1 (en) * | 2001-09-17 | 2003-04-10 | Infineon Technologies Ag | Biochip arrangement, sensor arrangement and method for operating a biochip arrangement |
DE10148102B4 (en) * | 2001-09-28 | 2006-03-30 | Biotez Berlin-Buch Gmbh | Biochip for the quantitative photometric detection of biomolecules, its use and method for the quantitative detection of biomolecules by photometric detection of a color reaction |
DE10149947A1 (en) | 2001-10-10 | 2003-04-17 | Febit Ferrarius Biotech Gmbh | Isolating target molecules, useful for separating e.g. nucleic acids for therapy or diagnosis, comprises passing the molecules through a microfluidics system that carries specific receptors |
DE10152925A1 (en) * | 2001-10-26 | 2003-05-08 | Febit Ag | Asymmetric probes |
DE10155892A1 (en) * | 2001-11-14 | 2003-05-28 | Infineon Technologies Ag | To identify macromolecular biopolymers, catch molecules are immobilized on a biosensor surface to form complexes with the macromolecular biopolymer in the sample for identification by signal intensity |
US7413859B2 (en) | 2001-11-14 | 2008-08-19 | Siemens Aktiengesellschaft | Method and biosensors for detecting macromolecular biopolymers |
DE10156467A1 (en) * | 2001-11-16 | 2003-06-05 | Micronas Gmbh | Carriers for synthesis and processes for the production of biopolymers |
US6677470B2 (en) | 2001-11-20 | 2004-01-13 | Natural Asa | Functional acylglycerides |
US7635588B2 (en) | 2001-11-29 | 2009-12-22 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
DE10160987B4 (en) * | 2001-12-05 | 2005-08-04 | Siemens Ag | Assembly for simultaneous, optical illumination of a large number of samples |
DE10201463B4 (en) | 2002-01-16 | 2005-07-21 | Clondiag Chip Technologies Gmbh | Reaction vessel for performing array method |
DE10206548B4 (en) * | 2002-02-13 | 2005-06-16 | Siemens Ag | Method for the analysis of support components carrying sample components and devices for carrying out this method |
DE10208770A1 (en) * | 2002-02-28 | 2003-09-04 | Febit Ag | Increasing the sensitivity and specificity of hybridization experiments with nucleic acid chips |
US7504364B2 (en) | 2002-03-01 | 2009-03-17 | Receptors Llc | Methods of making arrays and artificial receptors |
DE10215319A1 (en) * | 2002-04-02 | 2003-10-30 | Siemens Ag | Light source, for examination of sample on glass slide, is illuminated by array of light emitting diodes via lens system for charge coupled device camera |
EP3035037B1 (en) | 2002-05-17 | 2017-09-13 | Life Technologies Corporation | Apparatus for differentiating multiple fluorescence signals by excitation wavelength |
DE10224825A1 (en) * | 2002-06-05 | 2003-12-24 | Eppendorf Ag | Methods for the analysis of biomolecules |
FR2842826B1 (en) * | 2002-07-25 | 2006-01-20 | Centre Nat Rech Scient | PROCESS FOR PRODUCING BIOLOGICAL CHIPS |
JP2004069559A (en) | 2002-08-07 | 2004-03-04 | Seiko Epson Corp | Manufacturing system, its control device, control method, control system, and control program |
US7157228B2 (en) * | 2002-09-09 | 2007-01-02 | Bioarray Solutions Ltd. | Genetic analysis and authentication |
DE10242529A1 (en) * | 2002-09-12 | 2004-03-25 | Forschungszentrum Jülich GmbH | Portable optical system using photosensitive electrode to analyze one or more substances, includes light sources inside analysis container |
DE10242530A1 (en) * | 2002-09-12 | 2004-03-25 | Forschungszentrum Jülich GmbH | Light source, for measurement system based on photosensitive electrode, illuminates electrode locally for detection of one or more analytes |
US7469076B2 (en) | 2003-09-03 | 2008-12-23 | Receptors Llc | Sensors employing combinatorial artificial receptors |
US6743931B2 (en) | 2002-09-24 | 2004-06-01 | Natural Asa | Conjugated linoleic acid compositions |
DE10245432A1 (en) | 2002-09-27 | 2004-04-08 | Micronas Gmbh | Method and device for detecting at least one luminescent substance |
DE10245845B4 (en) * | 2002-09-30 | 2006-06-29 | INSTITUT FüR MIKROTECHNIK MAINZ GMBH | Measuring chip for the use of a device for the quantitative determination of an analyte in a sample and device with this measuring chip |
US7305112B2 (en) * | 2002-10-15 | 2007-12-04 | The Scripps Research Institute | Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media |
US7220592B2 (en) * | 2002-11-15 | 2007-05-22 | Eksigent Technologies, Llc | Particulate processing system |
US7175810B2 (en) | 2002-11-15 | 2007-02-13 | Eksigent Technologies | Processing of particles |
WO2004058393A2 (en) * | 2002-12-23 | 2004-07-15 | Febit Biotech Gmbh | Method for the validated construction of arrays |
US20060105388A1 (en) * | 2002-12-23 | 2006-05-18 | Febit Biothch Gmbh | Incorporation of hapten groups during the production of carriers for the determination of analytes |
DE10312670A1 (en) * | 2003-03-21 | 2004-10-07 | Friz Biochem Gmbh | Substrate for controlled wetting of predetermined wetting points with small liquid volumes, substrate cover and flow chamber |
WO2004085995A2 (en) * | 2003-03-24 | 2004-10-07 | Rosedale Medical Inc. | Analyte concentration detection devices and methods |
US7300755B1 (en) * | 2003-05-12 | 2007-11-27 | Fred Hutchinson Cancer Research Center | Methods for haplotyping genomic DNA |
JP2004361158A (en) * | 2003-06-03 | 2004-12-24 | Moritex Corp | Biochemical detection device and detection method |
US8133670B2 (en) * | 2003-06-13 | 2012-03-13 | Cold Spring Harbor Laboratory | Method for making populations of defined nucleic acid molecules |
US7718133B2 (en) * | 2003-10-09 | 2010-05-18 | 3M Innovative Properties Company | Multilayer processing devices and methods |
US20050209787A1 (en) * | 2003-12-12 | 2005-09-22 | Waggener Thomas B | Sequencing data analysis |
US7122799B2 (en) | 2003-12-18 | 2006-10-17 | Palo Alto Research Center Incorporated | LED or laser enabled real-time PCR system and spectrophotometer |
DE102004015272A1 (en) * | 2004-03-29 | 2005-11-03 | Infineon Technologies Ag | Biosensor to determine the presence of DNA comprises trap molecules that hybridize with the target molecules over photo diode detector |
DE102004021904B4 (en) * | 2004-05-04 | 2011-08-18 | Carl Zeiss Microlmaging GmbH, 07745 | Method and device for generating an analysis arrangement with discrete, separate measurement ranges for biological, biochemical or chemical analysis |
US7751048B2 (en) * | 2004-06-04 | 2010-07-06 | California Institute Of Technology | Optofluidic microscope device |
US7773227B2 (en) * | 2004-06-04 | 2010-08-10 | California Institute Of Technology | Optofluidic microscope device featuring a body comprising a fluid channel and having light transmissive regions |
US7522786B2 (en) * | 2005-12-22 | 2009-04-21 | Palo Alto Research Center Incorporated | Transmitting light with photon energy information |
US7291824B2 (en) * | 2005-12-22 | 2007-11-06 | Palo Alto Research Center Incorporated | Photosensing throughout energy range and in subranges |
WO2006029234A1 (en) | 2004-09-03 | 2006-03-16 | Receptors Llc | Combinatorial artificial receptors including tether building blocks |
DE102004056735A1 (en) | 2004-11-09 | 2006-07-20 | Clondiag Chip Technologies Gmbh | Device for performing and analyzing microarray experiments |
DE102004056787A1 (en) * | 2004-11-24 | 2006-06-01 | Heinrich-Heine-Universität Düsseldorf | Apparatus and method for measuring fluorescence in multiple reaction spaces |
TWI295730B (en) * | 2004-11-25 | 2008-04-11 | Ind Tech Res Inst | Microfluidic chip for sample assay and method thereof |
US7560417B2 (en) | 2005-01-13 | 2009-07-14 | Wisconsin Alumni Research Foundation | Method and apparatus for parallel synthesis of chain molecules such as DNA |
US8501416B2 (en) | 2005-04-19 | 2013-08-06 | President And Fellows Of Harvard College | Fluidic structures including meandering and wide channels |
GB0509833D0 (en) * | 2005-05-16 | 2005-06-22 | Isis Innovation | Cell analysis |
JP4607684B2 (en) * | 2005-06-29 | 2011-01-05 | 富士フイルム株式会社 | Flow path block, sensor unit, and measuring device using total reflection attenuation |
CA2623408C (en) | 2005-09-26 | 2014-04-01 | Rapid Micro Biosystems, Inc. | Cassette containing growth medium |
EP1795965B1 (en) * | 2005-12-08 | 2012-05-16 | Electronics and Telecommunications Research Institute | Programmable mask for fabricating biomolecule array or polymer array |
US7547904B2 (en) * | 2005-12-22 | 2009-06-16 | Palo Alto Research Center Incorporated | Sensing photon energies emanating from channels or moving objects |
US7433552B2 (en) * | 2005-12-22 | 2008-10-07 | Palo Alto Research Center Incorporated | Obtaining analyte information |
US7420677B2 (en) * | 2005-12-22 | 2008-09-02 | Palo Alto Research Center Incorporated | Sensing photon energies of optical signals |
US7358476B2 (en) * | 2005-12-22 | 2008-04-15 | Palo Alto Research Center Incorporated | Sensing photons from objects in channels |
US7386199B2 (en) * | 2005-12-22 | 2008-06-10 | Palo Alto Research Center Incorporated | Providing light to channels or portions |
US8437582B2 (en) | 2005-12-22 | 2013-05-07 | Palo Alto Research Center Incorporated | Transmitting light with lateral variation |
US11237171B2 (en) | 2006-02-21 | 2022-02-01 | Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
US8492098B2 (en) | 2006-02-21 | 2013-07-23 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of reaction components that affect a reaction |
US9041938B2 (en) | 2006-05-02 | 2015-05-26 | California Institute Of Technology | Surface wave assisted structures and systems |
US7768654B2 (en) | 2006-05-02 | 2010-08-03 | California Institute Of Technology | On-chip phase microscope/beam profiler based on differential interference contrast and/or surface plasmon assisted interference |
JP4431549B2 (en) * | 2006-05-31 | 2010-03-17 | 株式会社日立ハイテクノロジーズ | Fluorescence analyzer |
US20120269728A1 (en) * | 2006-08-02 | 2012-10-25 | Antara Biosciences Inc. | Methods and compositions for detecting one or more target agents using tracking components |
DE102006039479A1 (en) | 2006-08-23 | 2008-03-06 | Febit Biotech Gmbh | Programmable oligonucleotide synthesis |
WO2008049795A1 (en) * | 2006-10-23 | 2008-05-02 | Flexgen Bv | Method and system for calibrating laser focus and position in micro-arrays |
US7532128B2 (en) * | 2006-10-25 | 2009-05-12 | Alverix, Inc. | Position sensitive indicator detection |
DE102006056949B4 (en) * | 2006-11-30 | 2011-12-22 | Ruprecht-Karls-Universität Heidelberg | Method and device for detecting at least one property of at least one object with a microchip |
DE102007018833A1 (en) | 2007-04-20 | 2008-10-23 | Febit Holding Gmbh | Molecular-biological processing unit for detection, analysis of genomes, for producing e.g. synthetic nucleic acids, comprises device for in-situ-synthesis of arrays of receptors |
DE102006062089A1 (en) | 2006-12-29 | 2008-07-03 | Febit Holding Gmbh | Molecular biology process system comprises a device for synthesis of receptor arrays, devices for performing fluidic steps, a detection unit and programmable control units |
US9164037B2 (en) | 2007-01-26 | 2015-10-20 | Palo Alto Research Center Incorporated | Method and system for evaluation of signals received from spatially modulated excitation and emission to accurately determine particle positions and distances |
US8821799B2 (en) | 2007-01-26 | 2014-09-02 | Palo Alto Research Center Incorporated | Method and system implementing spatially modulated excitation or emission for particle characterization with enhanced sensitivity |
US7852490B2 (en) * | 2007-02-05 | 2010-12-14 | Palo Alto Research Center Incorporated | Implanting optical cavity structures |
US7936463B2 (en) * | 2007-02-05 | 2011-05-03 | Palo Alto Research Center Incorporated | Containing analyte in optical cavity structures |
US7633629B2 (en) * | 2007-02-05 | 2009-12-15 | Palo Alto Research Center Incorporated | Tuning optical cavities |
US7529438B2 (en) * | 2007-07-13 | 2009-05-05 | Palo Alto Research Center Incorporated | Producing fluidic waveguides |
US7522811B2 (en) * | 2007-07-13 | 2009-04-21 | Palo Alto Research Center Incorporated | Producing sandwich waveguides |
EP2020263B1 (en) * | 2007-07-27 | 2014-05-07 | F.Hoffmann-La Roche Ag | Orientation identification label, reagent container carrier structure and analyser device |
EP2201374B1 (en) | 2007-08-30 | 2015-10-07 | Trustees Of Tufts College | Methods for determining the concentration of an analyte in solution. |
DE202007019582U1 (en) | 2007-11-15 | 2014-01-30 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Measurement setup for detecting the distribution of at least one state variable in a measuring field with different probes |
DE102007054602A1 (en) * | 2007-11-15 | 2009-05-28 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Condition parameter's distribution detecting method for use in e.g. medical diagnosis, involves registering signals with different wavelengths from probes by using camera, and separately detecting signals based on output signals of camera |
DE102007056398A1 (en) | 2007-11-23 | 2009-05-28 | Febit Holding Gmbh | Flexible extraction method for the preparation of sequence-specific molecule libraries |
US8320983B2 (en) * | 2007-12-17 | 2012-11-27 | Palo Alto Research Center Incorporated | Controlling transfer of objects affecting optical characteristics |
US8373860B2 (en) | 2008-02-01 | 2013-02-12 | Palo Alto Research Center Incorporated | Transmitting/reflecting emanating light with time variation |
US8629981B2 (en) | 2008-02-01 | 2014-01-14 | Palo Alto Research Center Incorporated | Analyzers with time variation based on color-coded spatial modulation |
JP2011513752A (en) * | 2008-03-04 | 2011-04-28 | カリフォルニア インスティテュート オブ テクノロジー | Method using optofluidic microscope apparatus |
EP2252909A4 (en) * | 2008-03-04 | 2013-03-13 | California Inst Of Techn | OPTOFLUIDIC MICROSCOPE DEVICE WITH PHOTOCAPTER ARRAY |
US8325349B2 (en) * | 2008-03-04 | 2012-12-04 | California Institute Of Technology | Focal plane adjustment by back propagation in optofluidic microscope devices |
DE102008021365A1 (en) * | 2008-04-29 | 2009-01-22 | Siemens Aktiengesellschaft | Method for inserting reagents in microchannels of analyzer, involves providing dispensation unit by which reagents are dispensed, and analyzer, which has microchannels |
US8039776B2 (en) | 2008-05-05 | 2011-10-18 | California Institute Of Technology | Quantitative differential interference contrast (DIC) microscopy and photography based on wavefront sensors |
US8222047B2 (en) | 2008-09-23 | 2012-07-17 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
EP2340300B1 (en) | 2008-09-24 | 2013-12-18 | Straus Holdings Inc. | Method for detecting analytes |
WO2010036972A1 (en) * | 2008-09-25 | 2010-04-01 | The Trustees Of Columbia University In The City Of New York | Devices, apparatus and method for providing photostimulation and imaging of structures |
RU2385940C1 (en) * | 2008-10-23 | 2010-04-10 | Общество с ограниченной ответственностью "ВИНТЕЛ" | Method for real-time detection of nucleic acids by polymerase chain reaction and device for implementation thereof |
US8660312B2 (en) * | 2009-01-21 | 2014-02-25 | California Institute Of Technology | Quantitative differential interference contrast (DIC) devices for computed depth sectioning |
EP2398915B1 (en) | 2009-02-20 | 2016-08-24 | Synthetic Genomics, Inc. | Synthesis of sequence-verified nucleic acids |
WO2010106109A1 (en) | 2009-03-17 | 2010-09-23 | Febit Holding Gmbh | Multi-use of biochips |
DE102009014080B4 (en) * | 2009-03-23 | 2011-12-15 | Baumer Innotec Ag | Device for determining particle sizes |
FR2943789B1 (en) * | 2009-03-26 | 2013-07-26 | Commissariat Energie Atomique | METHOD AND DEVICE FOR CHARACTERIZING THE DYNAMIC OF COAGULATION OR SEDIMENTATION OF A FLUID SUCH AS BLOOD OR BLOOD PLASMA |
KR20100109196A (en) * | 2009-03-31 | 2010-10-08 | 삼성전자주식회사 | A system and method of measuring object's concentration using for transmission or reflection of light |
US8300971B2 (en) * | 2009-04-17 | 2012-10-30 | LevelSet Systems, Inc. | Method and apparatus for image processing for massive parallel DNA sequencing |
US8416400B2 (en) * | 2009-06-03 | 2013-04-09 | California Institute Of Technology | Wavefront imaging sensor |
WO2011035299A2 (en) * | 2009-09-21 | 2011-03-24 | California Institute Of Technology | Reflective focusing and transmissive projection device |
CN101698146B (en) * | 2009-09-24 | 2011-10-26 | 复旦大学附属肿瘤医院 | Microscale reactor for synthesizing radioactive drug and application thereof |
JP5012873B2 (en) * | 2009-10-14 | 2012-08-29 | カシオ計算機株式会社 | Image processing device |
JP2013509618A (en) | 2009-10-28 | 2013-03-14 | アレンティック マイクロサイエンス インコーポレイテッド | Microscopic imaging |
US9075225B2 (en) | 2009-10-28 | 2015-07-07 | Alentic Microscience Inc. | Microscopy imaging |
US20140152801A1 (en) | 2009-10-28 | 2014-06-05 | Alentic Microscience Inc. | Detecting and Using Light Representative of a Sample |
EP2496929B1 (en) * | 2009-11-05 | 2013-07-03 | Waterford Institute Of Technology | A nanohole array biosensor |
CN103026232B (en) | 2010-03-01 | 2015-02-04 | 匡特里克斯公司 | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
US8415171B2 (en) | 2010-03-01 | 2013-04-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
US9678068B2 (en) | 2010-03-01 | 2017-06-13 | Quanterix Corporation | Ultra-sensitive detection of molecules using dual detection methods |
US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
EP2550522B1 (en) * | 2010-03-23 | 2016-11-02 | California Institute of Technology | Super resolution optofluidic microscopes for 2d and 3d imaging |
DE102010018678B4 (en) | 2010-04-28 | 2017-06-29 | Sartorius Stedim Biotech Gmbh | Bioreactor arrangement, shaker and method for irradiating a medium in a bioreactor |
SE535918C2 (en) * | 2010-06-10 | 2013-02-19 | Hemocue Ab | Detection of magnetically labeled biological components |
US9114399B2 (en) | 2010-08-31 | 2015-08-25 | Canon U.S. Life Sciences, Inc. | System and method for serial processing of multiple nucleic acid assays |
WO2012030995A2 (en) * | 2010-08-31 | 2012-03-08 | Canon U.S. Life Sciences, Inc. | Optical system for high resolution thermal melt detection |
US8536545B2 (en) | 2010-09-09 | 2013-09-17 | California Institute Of Technology | Delayed emission detection devices and methods |
US9643184B2 (en) | 2010-10-26 | 2017-05-09 | California Institute Of Technology | e-Petri dishes, devices, and systems having a light detector for sampling a sequence of sub-pixel shifted projection images |
US9569664B2 (en) | 2010-10-26 | 2017-02-14 | California Institute Of Technology | Methods for rapid distinction between debris and growing cells |
US9426429B2 (en) | 2010-10-26 | 2016-08-23 | California Institute Of Technology | Scanning projective lensless microscope system |
DE102010056289A1 (en) | 2010-12-24 | 2012-06-28 | Geneart Ag | Process for the preparation of reading frame correct fragment libraries |
US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
CN103534627A (en) | 2011-03-03 | 2014-01-22 | 加州理工学院 | Light guided pixel |
WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
US8723140B2 (en) | 2011-08-09 | 2014-05-13 | Palo Alto Research Center Incorporated | Particle analyzer with spatial modulation and long lifetime bioprobes |
US9029800B2 (en) | 2011-08-09 | 2015-05-12 | Palo Alto Research Center Incorporated | Compact analyzer with spatial modulation and multiple intensity modulated excitation sources |
US9117149B2 (en) | 2011-10-07 | 2015-08-25 | Industrial Technology Research Institute | Optical registration carrier |
US9745546B2 (en) | 2011-11-07 | 2017-08-29 | Rapid Micro Biosystems, Inc. | Cassette for sterility testing |
KR20130073354A (en) * | 2011-12-23 | 2013-07-03 | 한국전자통신연구원 | Biochip analysis device |
CN107841461A (en) | 2012-04-16 | 2018-03-27 | 快速微型生物系统公司 | Cell culture apparatus |
WO2014113502A1 (en) | 2013-01-15 | 2014-07-24 | Quanterix Corporation | Detection of dna or rna using single molecule arrays and other techniques |
US10502666B2 (en) | 2013-02-06 | 2019-12-10 | Alentic Microscience Inc. | Sample processing improvements for quantitative microscopy |
WO2014168734A1 (en) * | 2013-03-15 | 2014-10-16 | Cedars-Sinai Medical Center | Time-resolved laser-induced fluorescence spectroscopy systems and uses thereof |
DE102013106432A1 (en) * | 2013-06-20 | 2014-12-24 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Optical indicator unit and device and method for determining a physico-chemical property of a process medium in a process plant |
CA2953620C (en) | 2013-06-26 | 2020-08-25 | Alentic Microscience Inc. | Sample processing improvements for microscopy |
CN107250716B (en) * | 2015-02-24 | 2020-07-24 | 国立大学法人东京大学 | Dynamic high-speed high-sensitivity imaging device and imaging method |
DE102015003019A1 (en) * | 2015-03-06 | 2016-09-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method and device for the optical detection of movement in a biological sample with spatial extent |
EP3104208B1 (en) * | 2015-06-09 | 2022-08-24 | Nokia Technologies Oy | Electronic circuitry for a valve for the transfer of an optically-active fluid from a first to a second reservoir |
WO2017010375A1 (en) * | 2015-07-10 | 2017-01-19 | ヤマト科学株式会社 | Tissue sample analysis device and tissue sample analysis system |
JP6239562B2 (en) * | 2015-09-14 | 2017-11-29 | 株式会社東芝 | LIGHTING DEVICE AND BIO INFORMATION MEASURING DEVICE INCLUDING THE SAME |
CN108351289B (en) | 2015-10-28 | 2021-11-26 | 国立大学法人东京大学 | Analysis device |
CN106248764B (en) * | 2016-08-03 | 2020-03-24 | 南京山诺生物科技有限公司 | Real-time visual sharing and integrated imaging nucleic acid electrophoresis device and operation method thereof |
KR20180046098A (en) * | 2016-10-27 | 2018-05-08 | 삼성전자주식회사 | Test Apparatus, Test System and Control Method of Test Apparatus |
DE102017127671A1 (en) * | 2017-11-23 | 2019-05-23 | Osram Opto Semiconductors Gmbh | Photonic gas sensor and method of making a photonic gas sensor |
CA3097748A1 (en) | 2018-04-19 | 2019-10-24 | First Light Biosciences, Inc. | Detection of targets |
WO2019241443A1 (en) | 2018-06-13 | 2019-12-19 | Thinkcyte Inc. | Methods and systems for cytometry |
CN109289725A (en) * | 2018-11-14 | 2019-02-01 | 山东金德新材料有限公司 | A kind of novel micro passage reaction |
EP3899423B1 (en) * | 2018-12-21 | 2024-04-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device, measurement system and method for capturing an at least partly reflective surface using two reflection patterns |
EP4357754A3 (en) | 2019-12-27 | 2024-07-10 | Thinkcyte, Inc. | Flow cytometer performance evaluation method and standard particle suspension |
WO2022010934A2 (en) * | 2020-07-07 | 2022-01-13 | Twist Bioscience Corporation | Devices and methods for light-directed polymer synthesis |
US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
US12251991B2 (en) | 2020-08-20 | 2025-03-18 | Denso International America, Inc. | Humidity control for olfaction sensors |
US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
US12017506B2 (en) | 2020-08-20 | 2024-06-25 | Denso International America, Inc. | Passenger cabin air control systems and methods |
US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
DE102020123949A1 (en) | 2020-09-15 | 2022-03-17 | IMMS Institut für Mikroelektronik- und Mechatronik-Systeme gemeinnützige GmbH (IMMS GmbH) | Electrochemical sensor arrangement and use of a photoelectric sensor for determining charge carriers in a medium |
WO2022217243A1 (en) * | 2021-04-07 | 2022-10-13 | Illumina, Inc. | Adaptable illumination pattern for sample analysis |
WO2023187429A1 (en) * | 2022-03-31 | 2023-10-05 | Thalesnano Zrt | Flow-through type apparatus for performing chemical reaction of reagents principally in space |
WO2024175788A2 (en) | 2023-02-23 | 2024-08-29 | Micropep Technologies S.A. | Methods and compositions for production and purification of peptides |
Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271957A (en) * | 1964-04-18 | 1966-09-13 | Dowty Technical Dev Ltd | Hydraulic apparatus |
US5104508A (en) * | 1987-06-18 | 1992-04-14 | Astroscan Ltd. | Analysis of carbohydrates |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5247180A (en) * | 1991-12-30 | 1993-09-21 | Texas Instruments Incorporated | Stereolithographic apparatus and method of use |
US5258295A (en) * | 1992-02-25 | 1993-11-02 | Glyko, Inc. | Fluorophore-assisted cloning analysis |
US5318679A (en) * | 1991-08-07 | 1994-06-07 | H & N Instruments, Inc. | Synthesis of chain chemical compounds |
US5384464A (en) * | 1989-09-22 | 1995-01-24 | Sim (Societe D'investissement Dans La Microscopie) S.A. | Process and apparatus for optical near field microlithography |
US5424186A (en) * | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5547839A (en) * | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5571639A (en) * | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5653939A (en) * | 1991-11-19 | 1997-08-05 | Massachusetts Institute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5677195A (en) * | 1991-11-22 | 1997-10-14 | Affymax Technologies N.V. | Combinatorial strategies for polymer synthesis |
US5723320A (en) * | 1995-08-29 | 1998-03-03 | Dehlinger; Peter J. | Position-addressable polynucleotide arrays |
US5728251A (en) * | 1995-09-27 | 1998-03-17 | Research Frontiers Inc | Light modulating film of improved UV stability for a light valve |
US5741411A (en) * | 1995-05-19 | 1998-04-21 | Iowa State University Research Foundation | Multiplexed capillary electrophoresis system |
US5755942A (en) * | 1994-11-10 | 1998-05-26 | David Sarnoff Research Center, Inc. | Partitioned microelectronic device array |
US5789162A (en) * | 1991-09-18 | 1998-08-04 | Affymax Technologies N.V. | Methods of synthesizing diverse collections of oligomers |
US5807525A (en) * | 1995-08-17 | 1998-09-15 | Hybridon, Inc. | Apparatus and process for multi stage solid phase synthesis of long chained organic molecules |
US5812272A (en) * | 1997-01-30 | 1998-09-22 | Hewlett-Packard Company | Apparatus and method with tiled light source array for integrated assay sensing |
US5843655A (en) * | 1995-09-18 | 1998-12-01 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
US5849486A (en) * | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
US5952172A (en) * | 1993-12-10 | 1999-09-14 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US5968745A (en) * | 1995-06-27 | 1999-10-19 | The University Of North Carolina At Chapel Hill | Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof |
US6001311A (en) * | 1997-02-05 | 1999-12-14 | Protogene Laboratories, Inc. | Apparatus for diverse chemical synthesis using two-dimensional array |
US6024925A (en) * | 1997-01-23 | 2000-02-15 | Sequenom, Inc. | Systems and methods for preparing low volume analyte array elements |
US6066448A (en) * | 1995-03-10 | 2000-05-23 | Meso Sclae Technologies, Llc. | Multi-array, multi-specific electrochemiluminescence testing |
US6295153B1 (en) * | 1998-06-04 | 2001-09-25 | Board Of Regents, The University Of Texas System | Digital optical chemistry micromirror imager |
US6309822B1 (en) * | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
US6375903B1 (en) * | 1998-02-23 | 2002-04-23 | Wisconsin Alumni Research Foundation | Method and apparatus for synthesis of arrays of DNA probes |
US20020160427A1 (en) * | 2001-04-27 | 2002-10-31 | Febit Ag | Methods and apparatuses for electronic determination of analytes |
US6582917B1 (en) * | 1998-09-15 | 2003-06-24 | Deutsches Krebsforschungszentrum | Method for controlling quality in the construction of oligomer grids |
US6586211B1 (en) * | 1999-02-19 | 2003-07-01 | Febit Ferrarius Biotechnology Gmbh | Method for producing polymers |
US20040043509A1 (en) * | 2000-10-17 | 2004-03-04 | Stahler Cord F. | Method and device for the integrated synthesis and analysis of analytes on a support |
US20040175734A1 (en) * | 1998-08-28 | 2004-09-09 | Febit Ferrarius Biotechnology Gmbh | Support for analyte determination methods and method for producing the support |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342832A (en) | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
DE3301833A1 (en) | 1983-01-20 | 1984-07-26 | Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig | METHOD FOR SIMULTANEOUS SYNTHESIS OF SEVERAL OLIGONOCLEOTIDES IN A SOLID PHASE |
DE8309254U1 (en) | 1983-03-29 | 1985-01-03 | Straub, Hans, Dipl.-Ing.(FH), 7345 Deggingen | DISTRIBUTION UNIT FOR THE PIPES OF CENTRAL HEATING SYSTEMS |
DE3322373C2 (en) * | 1983-05-19 | 1986-12-04 | Ioannis Dr. 3000 Hannover Tripatzis | Test means and methods for the detection of antigens and / or antibodies |
SE8303626D0 (en) | 1983-06-23 | 1983-06-23 | Kabigen Ab | A RECOMBINANT PLASMID AND A TRANSFORMANT MICROORGANISM, A POLYDOXYREBONUCLEOTIDE SEGMENT, A PROCESS FOR PRODUCING A BIOLOGICALLY ACTIVE PROTEIN, AND THE PROTEIN THUS PRODUCED |
ATE143289T1 (en) * | 1984-06-13 | 1996-10-15 | Applied Research Systems | APPARATUS USED IN CHEMICAL TESTING PROCEDURES |
EP0316018A3 (en) | 1985-03-29 | 1989-07-26 | Cetus Oncology Corporation | Modification of dna sequences |
SE458968B (en) * | 1987-06-16 | 1989-05-22 | Wallac Oy | BIOSPECIFIC ANALYTICAL PROCEDURE FOR MULTIPLE ANALYTICS WHICH DO NOT INCLUDE PARTICULAR COATING AND LABELING WITH FLUORESCING LABEL SUBSTANCES |
US5162863A (en) * | 1988-02-15 | 1992-11-10 | Canon Kabushiki Kaisha | Method and apparatus for inspecting a specimen by optical detection of antibody/antigen sensitized carriers |
AU3869289A (en) | 1988-07-14 | 1990-02-05 | Baylor College Of Medicine | Solid phase assembly and reconstruction of biopolymers |
ATE143696T1 (en) | 1989-02-28 | 1996-10-15 | Canon Kk | PARTIALLY DOUBLE STRANDED OLIGONUCLEOTIDE AND METHOD FOR FORMING IT |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5925525A (en) * | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
AU642444B2 (en) | 1989-11-30 | 1993-10-21 | Mochida Pharmaceutical Co., Ltd. | Reaction vessel |
WO1991018276A1 (en) | 1990-05-22 | 1991-11-28 | Kelly Kenneth A | Microassay strip device for immunoassay |
US5239178A (en) * | 1990-11-10 | 1993-08-24 | Carl Zeiss | Optical device with an illuminating grid and detector grid arranged confocally to an object |
DE69133293T2 (en) * | 1990-12-06 | 2004-05-27 | Affymetrix, Inc., Santa Clara | Processes and reagents for immobilized polymer synthesis on a very large scale |
DE69130251T2 (en) | 1990-12-28 | 1999-05-27 | Matsushita Electric Industrial Co., Ltd., Kadoma, Osaka | Process for the formation of ultra-fine structures |
US5239176A (en) * | 1991-10-03 | 1993-08-24 | Foster-Miller, Inc. | Tapered optical fiber sensing attenuated total reflectance |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US6048690A (en) | 1991-11-07 | 2000-04-11 | Nanogen, Inc. | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
GB9206671D0 (en) | 1992-03-27 | 1992-05-13 | Cranfield Biotech Ltd | Electrochemical detection of dna hybridisation |
DE69334326D1 (en) * | 1992-09-14 | 2010-05-20 | Stanford Res Inst Int | Up-converting reporter molecules for biological and other testing using laser excitation techniques |
WO1994012632A1 (en) | 1992-11-27 | 1994-06-09 | University College London | Improvements in nucleic acid synthesis by pcr |
DE4241871A1 (en) | 1992-12-11 | 1994-06-16 | Schulz Rudolf Ing Grad | Coupled circuit elements for optical molecular computer with associative memories - are combined into bio-chip by enzyme reactions yielding microscopic metallic particles for conduction of program and data signals |
US5368823A (en) | 1993-02-11 | 1994-11-29 | University Of Georgia Research Foundation, Inc. | Automated synthesis of oligonucleotides |
WO1995001559A2 (en) | 1993-07-02 | 1995-01-12 | Evotec Biosystems Gmbh | Sample holder and its use |
DE4325724A1 (en) | 1993-07-30 | 1995-02-02 | Paul Dr Debbage | Device and method for examining an object and for affecting the object |
DE69328693T2 (en) | 1993-09-28 | 2000-08-31 | Beckman Coulter, Inc. | BIOPOLYMERSYNTHESIS BY SURFACE-ACTIVATED ORGANIC POLYMERS |
US5824473A (en) | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
DE4343591A1 (en) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Process for the evolutionary design and synthesis of functional polymers based on shape elements and shape codes |
EP0671626B1 (en) | 1994-03-08 | 2000-01-12 | Zeptosens AG | Device and method for combined bioaffinity assay and electrophoretic separation |
US5707799A (en) | 1994-09-30 | 1998-01-13 | Abbott Laboratories | Devices and methods utilizing arrays of structures for analyte capture |
US6974666B1 (en) * | 1994-10-21 | 2005-12-13 | Appymetric, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
JPH08136546A (en) * | 1994-11-15 | 1996-05-31 | Bio Sensor Kenkyusho:Kk | Method for analyzing substance |
US5891738A (en) * | 1995-01-16 | 1999-04-06 | Erkki Soini | Biospecific multiparameter assay method |
US5959098A (en) | 1996-04-17 | 1999-09-28 | Affymetrix, Inc. | Substrate preparation process |
US5736257A (en) | 1995-04-25 | 1998-04-07 | Us Navy | Photoactivatable polymers for producing patterned biomolecular assemblies |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
AU6752496A (en) | 1995-07-28 | 1997-03-05 | Ely Michael Rabani | Pattern formation, replication, fabrication and devices thereby |
US5667195A (en) * | 1995-11-13 | 1997-09-16 | Matthew Howard McCormick | Fluid drain apparatus |
US5763263A (en) * | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US5747349A (en) * | 1996-03-20 | 1998-05-05 | University Of Washington | Fluorescent reporter beads for fluid analysis |
US6020481A (en) | 1996-04-01 | 2000-02-01 | The Perkin-Elmer Corporation | Asymmetric benzoxanthene dyes |
JP3233851B2 (en) | 1996-04-24 | 2001-12-04 | 繁織 竹中 | Electrochemical detection method of gene and its device |
WO1997041425A1 (en) | 1996-04-25 | 1997-11-06 | Pence, Inc. | Biosensor device and method |
US5851804A (en) | 1996-05-06 | 1998-12-22 | Apollon, Inc. | Chimeric kanamycin resistance gene |
WO1998003683A1 (en) | 1996-07-19 | 1998-01-29 | The Regents Of The University Of Michigan | Dna encoding canine von willebrand factor and methods of use |
US5871628A (en) | 1996-08-22 | 1999-02-16 | The University Of Texas System | Automatic sequencer/genotyper having extended spectral response |
WO1998013683A1 (en) | 1996-09-26 | 1998-04-02 | Sarnoff Corporation | Massively parallel detection |
GB9621122D0 (en) * | 1996-10-10 | 1996-11-27 | Cambridge Imaging Ltd | Improvements in and relating to methods and apparatus for assay analysis |
IES80556B2 (en) | 1997-01-10 | 1998-09-23 | Robert Arpad Foster | Electrochemical diagnostic detection device |
US5985214A (en) * | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
DE69838067T2 (en) | 1997-05-23 | 2008-03-13 | Bioarray Solutions Ltd. | COLOR CODING AND SITU INQUIRY OF MATRIX-COUPLED CHEMICAL COMPOUNDS |
CA2291180A1 (en) * | 1997-05-23 | 1998-11-26 | Lynx Therapeutics, Inc. | System and apparatus for sequential processing of analytes |
DE19726634A1 (en) | 1997-06-18 | 1998-12-24 | Biotools Inst Fuer Computerint | Method and device for immobilizing macromolecules |
EP1003759A2 (en) | 1997-08-13 | 2000-05-31 | Cepheid | Microstructures for the manipulation of fluid samples |
JP3938982B2 (en) * | 1997-08-29 | 2007-06-27 | オリンパス株式会社 | DNA capillary |
PT1538206E (en) | 1997-09-16 | 2010-04-12 | Centocor Ortho Biotech Inc | Method for the complete chemical synthesis and assembly of genes and genomes |
WO1999019510A1 (en) | 1997-10-10 | 1999-04-22 | President And Fellows Of Harvard College | Surface-bound, double-stranded dna protein arrays |
US6177558B1 (en) | 1997-11-13 | 2001-01-23 | Protogene Laboratories, Inc. | Method and composition for chemical synthesis using high boiling point organic solvents to control evaporation |
US6197503B1 (en) | 1997-11-26 | 2001-03-06 | Ut-Battelle, Llc | Integrated circuit biochip microsystem containing lens |
US6242246B1 (en) | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
US20020076735A1 (en) * | 1998-09-25 | 2002-06-20 | Williams Lewis T. | Diagnostic and therapeutic methods using molecules differentially expressed in cancer cells |
US7090804B2 (en) | 1998-01-27 | 2006-08-15 | Clinical Mirco Sensors, Inc. | Amplification of nucleic acids with electronic detection |
WO1999039817A1 (en) | 1998-02-06 | 1999-08-12 | Affymetrix, Inc. | Method of quality control in manufacturing processes |
EP2332645A1 (en) | 1998-02-11 | 2011-06-15 | The University Of Houston | Apparatus for chemical and biochemical reactions using photo-generated reagents |
US6130046A (en) | 1998-05-04 | 2000-10-10 | Affymetrix, Inc. | Techniques for synthesis integrity evaluation utilizing cycle fidelity probes |
DE19823454A1 (en) | 1998-05-18 | 1999-11-25 | Epigenomics Gmbh | Photolithographic production of oligonucleotide array for manufacture of DNA chips |
AU4194899A (en) | 1998-05-21 | 1999-12-06 | Hyseq, Inc. | Linear arrays of immobilized compounds and methods of using same |
DE19823876B4 (en) | 1998-05-28 | 2004-07-22 | INSTITUT FüR MIKROTECHNIK MAINZ GMBH | Component loaded with different connections (biochip) and method for its production |
US6271957B1 (en) | 1998-05-29 | 2001-08-07 | Affymetrix, Inc. | Methods involving direct write optical lithography |
US6908770B1 (en) * | 1998-07-16 | 2005-06-21 | Board Of Regents, The University Of Texas System | Fluid based analysis of multiple analytes by a sensor array |
RU2161653C2 (en) | 1998-08-24 | 2001-01-10 | ФАРМАКОВСКИЙ Дмитрий Александрович | Method of quantitative electrochemical analysis of biological molecules |
DE19964220C2 (en) | 1998-11-23 | 2003-07-03 | Friz Biochem Gmbh | Modified nucleic acid oligomer, useful for sequencing by hybridization, is substituted by redox agent to allow electrical detection of hybridization |
DE19921940C2 (en) | 1998-11-23 | 2003-02-06 | Friz Biochem Gmbh | Method for the electrochemical detection of nucleic acid oligomer hybrids |
DE19901761A1 (en) | 1999-01-18 | 1999-07-01 | Gerhard Dr Hartwich | Oligonucleotides tagged with photoinducible redox-active unit |
CN1352697A (en) | 1999-01-18 | 2002-06-05 | 弗里兹生物化学有限公司 | Method for electrochemically detecting nucleic acid oligomer hybridisation events |
DE19910392B4 (en) | 1999-03-05 | 2005-03-17 | Clondiag Chip Technologies Gmbh | Micro column reactor |
EP1159285B1 (en) | 1999-03-08 | 2005-05-25 | Metrigen, Inc. | Methods and compositions for economically synthesizing and assembling long dna sequences |
US6114123A (en) * | 1999-06-14 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Lipocalin family protein |
AU2002210552A1 (en) | 2000-10-17 | 2002-04-29 | Febit Ag | Method and device for the integrated synthesis and analysis of analytes on a support |
-
1999
- 1999-08-27 DE DE19940751A patent/DE19940751A1/en not_active Withdrawn
- 1999-08-27 JP JP2000571081A patent/JP2002525590A/en active Pending
- 1999-08-27 DE DE59912120T patent/DE59912120D1/en not_active Expired - Lifetime
- 1999-08-27 EP EP10176218A patent/EP2273270A1/en not_active Withdrawn
- 1999-08-27 DE DE19940810A patent/DE19940810A1/en not_active Withdrawn
- 1999-08-27 AU AU57424/99A patent/AU749884B2/en not_active Ceased
- 1999-08-27 JP JP2000571025A patent/JP2002525587A/en active Pending
- 1999-08-27 AT AT99968261T patent/ATE481637T1/en active
- 1999-08-27 EP EP99968261A patent/EP1117996B1/en not_active Expired - Lifetime
- 1999-08-27 EP EP99942927A patent/EP1115424A1/en not_active Withdrawn
- 1999-08-27 EP EP03028140A patent/EP1405666B1/en not_active Revoked
- 1999-08-27 CA CA002341894A patent/CA2341894A1/en not_active Abandoned
- 1999-08-27 EP EP99944538A patent/EP1117478B1/en not_active Expired - Lifetime
- 1999-08-27 WO PCT/EP1999/006317 patent/WO2000013018A2/en active IP Right Grant
- 1999-08-27 DE DE19940749A patent/DE19940749A1/en not_active Withdrawn
- 1999-08-27 CA CA002341896A patent/CA2341896A1/en not_active Abandoned
- 1999-08-27 JP JP2000567951A patent/JP2002523781A/en active Pending
- 1999-08-27 AU AU59713/99A patent/AU771238B2/en not_active Ceased
- 1999-08-27 EP EP06020037A patent/EP1742058B1/en not_active Expired - Lifetime
- 1999-08-27 AT AT03028140T patent/ATE357289T1/en not_active IP Right Cessation
- 1999-08-27 AU AU56253/99A patent/AU760425B2/en not_active Ceased
- 1999-08-27 US US09/763,607 patent/US7737088B1/en not_active Expired - Fee Related
- 1999-08-27 DE DE59914270T patent/DE59914270D1/en not_active Expired - Lifetime
- 1999-08-27 DE DE19940750A patent/DE19940750A1/en not_active Withdrawn
- 1999-08-27 AT AT99944538T patent/ATE296677T1/en not_active IP Right Cessation
- 1999-08-27 WO PCT/EP1999/006316 patent/WO2000013017A2/en active IP Right Grant
- 1999-08-27 AT AT06020037T patent/ATE535814T1/en active
- 1999-08-27 WO PCT/EP1999/006315 patent/WO2000012123A2/en not_active Application Discontinuation
- 1999-08-27 US US09/763,914 patent/US7097974B1/en not_active Expired - Fee Related
- 1999-08-27 DE DE19940752A patent/DE19940752A1/en not_active Withdrawn
- 1999-08-27 DE DE59915204T patent/DE59915204D1/en not_active Expired - Lifetime
-
2003
- 2003-12-05 US US10/727,566 patent/US20040175734A1/en not_active Abandoned
-
2006
- 2006-08-28 US US11/510,565 patent/US20070031877A1/en not_active Abandoned
-
2008
- 2008-01-09 US US11/971,805 patent/US20080214412A1/en not_active Abandoned
Patent Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271957A (en) * | 1964-04-18 | 1966-09-13 | Dowty Technical Dev Ltd | Hydraulic apparatus |
US5104508A (en) * | 1987-06-18 | 1992-04-14 | Astroscan Ltd. | Analysis of carbohydrates |
US6309822B1 (en) * | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
US6420169B1 (en) * | 1989-06-07 | 2002-07-16 | Affymetrix, Inc. | Apparatus for forming polynucleotides or polypeptides |
US5405783A (en) * | 1989-06-07 | 1995-04-11 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of an array of polymers |
US5424186A (en) * | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5547839A (en) * | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5384464A (en) * | 1989-09-22 | 1995-01-24 | Sim (Societe D'investissement Dans La Microscopie) S.A. | Process and apparatus for optical near field microlithography |
US5318679A (en) * | 1991-08-07 | 1994-06-07 | H & N Instruments, Inc. | Synthesis of chain chemical compounds |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5789162A (en) * | 1991-09-18 | 1998-08-04 | Affymax Technologies N.V. | Methods of synthesizing diverse collections of oligomers |
US5653939A (en) * | 1991-11-19 | 1997-08-05 | Massachusetts Institute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5846708A (en) * | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5677195A (en) * | 1991-11-22 | 1997-10-14 | Affymax Technologies N.V. | Combinatorial strategies for polymer synthesis |
US6136269A (en) * | 1991-11-22 | 2000-10-24 | Affymetrix, Inc. | Combinatorial kit for polymer synthesis |
US5247180A (en) * | 1991-12-30 | 1993-09-21 | Texas Instruments Incorporated | Stereolithographic apparatus and method of use |
US5258295A (en) * | 1992-02-25 | 1993-11-02 | Glyko, Inc. | Fluorophore-assisted cloning analysis |
US5849486A (en) * | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
US5952172A (en) * | 1993-12-10 | 1999-09-14 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US5571639A (en) * | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5755942A (en) * | 1994-11-10 | 1998-05-26 | David Sarnoff Research Center, Inc. | Partitioned microelectronic device array |
US6066448A (en) * | 1995-03-10 | 2000-05-23 | Meso Sclae Technologies, Llc. | Multi-array, multi-specific electrochemiluminescence testing |
US5741411A (en) * | 1995-05-19 | 1998-04-21 | Iowa State University Research Foundation | Multiplexed capillary electrophoresis system |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5968745A (en) * | 1995-06-27 | 1999-10-19 | The University Of North Carolina At Chapel Hill | Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof |
US5807525A (en) * | 1995-08-17 | 1998-09-15 | Hybridon, Inc. | Apparatus and process for multi stage solid phase synthesis of long chained organic molecules |
US5723320A (en) * | 1995-08-29 | 1998-03-03 | Dehlinger; Peter J. | Position-addressable polynucleotide arrays |
US5843655A (en) * | 1995-09-18 | 1998-12-01 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
US6238862B1 (en) * | 1995-09-18 | 2001-05-29 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
US5728251A (en) * | 1995-09-27 | 1998-03-17 | Research Frontiers Inc | Light modulating film of improved UV stability for a light valve |
US6024925A (en) * | 1997-01-23 | 2000-02-15 | Sequenom, Inc. | Systems and methods for preparing low volume analyte array elements |
US5812272A (en) * | 1997-01-30 | 1998-09-22 | Hewlett-Packard Company | Apparatus and method with tiled light source array for integrated assay sensing |
US6001311A (en) * | 1997-02-05 | 1999-12-14 | Protogene Laboratories, Inc. | Apparatus for diverse chemical synthesis using two-dimensional array |
US6375903B1 (en) * | 1998-02-23 | 2002-04-23 | Wisconsin Alumni Research Foundation | Method and apparatus for synthesis of arrays of DNA probes |
US6295153B1 (en) * | 1998-06-04 | 2001-09-25 | Board Of Regents, The University Of Texas System | Digital optical chemistry micromirror imager |
US20040175734A1 (en) * | 1998-08-28 | 2004-09-09 | Febit Ferrarius Biotechnology Gmbh | Support for analyte determination methods and method for producing the support |
US6582917B1 (en) * | 1998-09-15 | 2003-06-24 | Deutsches Krebsforschungszentrum | Method for controlling quality in the construction of oligomer grids |
US20030175781A1 (en) * | 1998-09-15 | 2003-09-18 | Markus Beier | Method for controlling quality in the construction of oligomer arrays |
US6586211B1 (en) * | 1999-02-19 | 2003-07-01 | Febit Ferrarius Biotechnology Gmbh | Method for producing polymers |
US20030198948A1 (en) * | 1999-02-19 | 2003-10-23 | Stahler Peer F. | Method for producing polymers |
US20040043509A1 (en) * | 2000-10-17 | 2004-03-04 | Stahler Cord F. | Method and device for the integrated synthesis and analysis of analytes on a support |
US20020160427A1 (en) * | 2001-04-27 | 2002-10-31 | Febit Ag | Methods and apparatuses for electronic determination of analytes |
US20050037407A1 (en) * | 2001-04-27 | 2005-02-17 | Febit Ag | Methods and apparatuses for electronic determination of analytes |
Cited By (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071393B2 (en) | 1996-04-25 | 2011-12-06 | Bioarray Solutions, Ltd. | Method of analyzing nucleic acids using an array of encoded beads |
US9400259B2 (en) | 1996-04-25 | 2016-07-26 | Bioarray Solutions, Ltd. | Method of making a microbead array with attached biomolecules |
US20060228740A1 (en) * | 1996-04-25 | 2006-10-12 | Michael Seul | Light-controlled electrokinetic assembly of particles near surfaces |
US20060228741A1 (en) * | 1996-04-25 | 2006-10-12 | Seul Michael | Light-controlled electrokinetic assembly of particles near surfaces |
US20070154934A1 (en) * | 1996-04-25 | 2007-07-05 | Michael Seul | Assays Employing Randomly Distributed Microbeads with Attached Biomolecules |
US20070259449A1 (en) * | 1996-04-25 | 2007-11-08 | Michael Seul | Method of making a microbead array with attached biomolecules |
US8691594B2 (en) | 1996-04-25 | 2014-04-08 | Bioarray Solutions, Ltd. | Method of making a microbead array with attached biomolecules |
US8309368B2 (en) | 1996-04-25 | 2012-11-13 | Bioarray Solutions, Ltd. | Method of making a microbead array with attached biomolecules |
US8124402B2 (en) | 1996-04-25 | 2012-02-28 | Bioarray Solutions, Ltd. | Encoded beads having oligonucleotides attached in arrays on a patterned surface |
US8039271B2 (en) | 1996-04-25 | 2011-10-18 | Bioarray Solutions, Ltd. | Assays employing randomly distributed microbeads with attached biomolecules |
US20080038844A1 (en) * | 1996-04-25 | 2008-02-14 | Michael Seul | Method of Analyzing Nucleic Acids Using an Array of Encoded Beads |
US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
US8486720B2 (en) | 2000-06-21 | 2013-07-16 | Bioarray Solutions, Ltd. | Arrays of magnetic particles |
US20050272049A1 (en) * | 2000-06-21 | 2005-12-08 | Sukanta Banerjee | Arrays of magnetic particles |
US9436088B2 (en) | 2001-06-21 | 2016-09-06 | Bioarray Solutions, Ltd. | Un-supported polymeric film with embedded microbeads |
US10415081B2 (en) | 2001-10-15 | 2019-09-17 | Bioarray Solutions Ltd. | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US8712123B2 (en) | 2002-11-15 | 2014-04-29 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
US9251583B2 (en) | 2002-11-15 | 2016-02-02 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
US8615367B2 (en) | 2003-09-18 | 2013-12-24 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
US20110184655A1 (en) * | 2003-09-18 | 2011-07-28 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
US8691754B2 (en) | 2003-09-22 | 2014-04-08 | Bioarray Solutions, Ltd. | Microparticles with enhanced covalent binding capacity and their uses |
US20100331213A1 (en) * | 2003-09-22 | 2010-12-30 | Bioarray Solutions, Ltd. | Microparticles with enhanced covalent binding capacity and their uses |
US20050089916A1 (en) * | 2003-10-28 | 2005-04-28 | Xiongwu Xia | Allele assignment and probe selection in multiplexed assays of polymorphic targets |
US9637777B2 (en) | 2003-10-28 | 2017-05-02 | Bioarray Solutions, Ltd. | Optimization of gene expression analysis using immobilized capture probes |
US8795960B2 (en) | 2003-10-28 | 2014-08-05 | Bioarray Solutions, Ltd. | Optimization of gene expression analysis using immobilized capture probes |
US8563247B2 (en) | 2003-10-29 | 2013-10-22 | Bioarray Solutions, Ltd. | Kits for multiplexed nucleic acid analysis by capture of single-stranded DNA produced from double-stranded target fragments |
US20080140452A1 (en) * | 2004-07-09 | 2008-06-12 | Michael Seul | Transfusion registry network for genetically characterized blood products |
US9147037B2 (en) | 2004-08-02 | 2015-09-29 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
US20080160548A1 (en) * | 2005-04-20 | 2008-07-03 | Micronas Gmbh | Microoptical Detection System and Method for Determination of Temperature-Dependent Parameters of Analytes |
US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
US9403141B2 (en) | 2013-08-05 | 2016-08-02 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10272410B2 (en) | 2013-08-05 | 2019-04-30 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US9555388B2 (en) | 2013-08-05 | 2017-01-31 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US9833761B2 (en) | 2013-08-05 | 2017-12-05 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US9839894B2 (en) | 2013-08-05 | 2017-12-12 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US9889423B2 (en) | 2013-08-05 | 2018-02-13 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US11452980B2 (en) | 2013-08-05 | 2022-09-27 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10639609B2 (en) | 2013-08-05 | 2020-05-05 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10632445B2 (en) | 2013-08-05 | 2020-04-28 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US11559778B2 (en) | 2013-08-05 | 2023-01-24 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10384188B2 (en) | 2013-08-05 | 2019-08-20 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US9409139B2 (en) | 2013-08-05 | 2016-08-09 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US11185837B2 (en) | 2013-08-05 | 2021-11-30 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10773232B2 (en) | 2013-08-05 | 2020-09-15 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10583415B2 (en) | 2013-08-05 | 2020-03-10 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US10618024B2 (en) | 2013-08-05 | 2020-04-14 | Twist Bioscience Corporation | De novo synthesized gene libraries |
US11697668B2 (en) | 2015-02-04 | 2023-07-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
US9677067B2 (en) | 2015-02-04 | 2017-06-13 | Twist Bioscience Corporation | Compositions and methods for synthetic gene assembly |
US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
US10744477B2 (en) | 2015-04-21 | 2020-08-18 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
US11691118B2 (en) | 2015-04-21 | 2023-07-04 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
US10844373B2 (en) | 2015-09-18 | 2020-11-24 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
US11807956B2 (en) | 2015-09-18 | 2023-11-07 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
US11512347B2 (en) | 2015-09-22 | 2022-11-29 | Twist Bioscience Corporation | Flexible substrates for nucleic acid synthesis |
US10384189B2 (en) | 2015-12-01 | 2019-08-20 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
US10987648B2 (en) | 2015-12-01 | 2021-04-27 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
US9895673B2 (en) | 2015-12-01 | 2018-02-20 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
US10975372B2 (en) | 2016-08-22 | 2021-04-13 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
US10053688B2 (en) | 2016-08-22 | 2018-08-21 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
US12056264B2 (en) | 2016-09-21 | 2024-08-06 | Twist Bioscience Corporation | Nucleic acid based data storage |
US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
US11263354B2 (en) | 2016-09-21 | 2022-03-01 | Twist Bioscience Corporation | Nucleic acid based data storage |
US11562103B2 (en) | 2016-09-21 | 2023-01-24 | Twist Bioscience Corporation | Nucleic acid based data storage |
US10754994B2 (en) | 2016-09-21 | 2020-08-25 | Twist Bioscience Corporation | Nucleic acid based data storage |
US10907274B2 (en) | 2016-12-16 | 2021-02-02 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
US11550939B2 (en) | 2017-02-22 | 2023-01-10 | Twist Bioscience Corporation | Nucleic acid based data storage using enzymatic bioencryption |
US10894959B2 (en) | 2017-03-15 | 2021-01-19 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
US11377676B2 (en) | 2017-06-12 | 2022-07-05 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
US11332740B2 (en) | 2017-06-12 | 2022-05-17 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
US10696965B2 (en) | 2017-06-12 | 2020-06-30 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
US10894242B2 (en) | 2017-10-20 | 2021-01-19 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
US11745159B2 (en) | 2017-10-20 | 2023-09-05 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
US12086722B2 (en) | 2018-01-04 | 2024-09-10 | Twist Bioscience Corporation | DNA-based digital information storage with sidewall electrodes |
US10936953B2 (en) | 2018-01-04 | 2021-03-02 | Twist Bioscience Corporation | DNA-based digital information storage with sidewall electrodes |
US11732294B2 (en) | 2018-05-18 | 2023-08-22 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
US11492665B2 (en) | 2018-05-18 | 2022-11-08 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
US11684903B2 (en) | 2018-10-24 | 2023-06-27 | Daniel Shafer | Microscale chemical reactors |
US11492728B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
US11492727B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for GLP1 receptor |
US11332738B2 (en) | 2019-06-21 | 2022-05-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
US12173282B2 (en) | 2019-09-23 | 2024-12-24 | Twist Bioscience, Inc. | Antibodies that bind CD3 epsilon |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7097974B1 (en) | Support for a method for determining an analyte and a method for producing the support | |
US7410763B2 (en) | Multiplex data collection and analysis in bioanalyte detection | |
US6756223B2 (en) | Electro-chemical analysis device with integrated thermal sensor and method for monitoring a sample using the device | |
AU753307B2 (en) | Capillary electroflow apparatus and method | |
US20030138969A1 (en) | Closed substrate platforms suitable for analysis of biomolecules | |
JP2002525600A (en) | Miniaturized cell array method and device for cell-based screening | |
JP2000512009A (en) | Miniaturized cell array method and apparatus for performing cell-based screening | |
US20080207461A1 (en) | Devices for Conducting and Analyzing Microarray Experiments | |
US20030068639A1 (en) | Detecting biochemical reactions | |
US8097421B2 (en) | Method for performing a multiplex immunoassay using label disassociation and an integrated substrate | |
US20030203366A1 (en) | Microarray channel devices produced by a block mold process | |
US20070141576A1 (en) | Biological chip and use thereof | |
JP2003232791A (en) | Probe solid-phase reaction array | |
EP1229129A2 (en) | Affinity detecting/analytical chip, method for production thereof, detection method and detection system using same | |
JP4262512B2 (en) | Probe-immobilized reaction array | |
CN100406887C (en) | Tubular biochip | |
Rabiee et al. | Microarray technologies | |
JP2004170372A (en) | Manufacturing method of biomolecule detecting device | |
JP2004301559A (en) | Probe solid phase reaction array and its using method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |